





Title of Dissertation:               MODULATION OF P21 HUMAN TUMOR 
SUPPRESSOR GENE EXPRESSION BY ZINC STATUS 
IN HUMAN HEPATOBLASTOMA AND NORMAL 
HUMAN BRONCHIAL EPITHELIAL CELLS 
 
 
                        Hon-Kit Wong, Doctor of Philosophy, 2007 
 
 
Dissertation directed by:         Professor David K.Y. Lei 




The transcriptional regulation of p21 gene in both human hepatoblastoma (HepG2) 
cells and normal human bronchial epithelial (NHBE) cells in response to different zinc 
status has been examined. In both zinc deficient (ZD) and zinc marginal deficient (ZD0.4) 
HepG2 cells, the p21 mRNA and nuclear protein levels as well as p21 promoter activity 
were repressed as compared to that of zinc normal (ZN) control cells. However, they 
were not altered in zinc adequate (ZA) and zinc supplement (ZS) cells as compared to ZN 
cells. Moreover, transfection of a construct consisted of a constitutive promoter fused 
with a full length p21 coding sequence in ZD cells, normalized p21 protein expression to 
that of the ZN cells, but failed to correct cell growth reduction. Similar transfection in ZN 
cells overexpressed p21 and repressed cell growth. Thus, the present data indicate that in 
zinc-deficient HepG2 cells, the p21 transcriptional process is depressed. However, 
depressed p21 transcriptional process is not responsible for repressed cell growth in zinc-
deficient HepG2 cells. 
 
 
In NHBE cells, the nuclear p21 protein level and mRNA abundance as well as 
promoter activity in ZS cells, but not in ZD cells, were markedly elevated to almost 2-
fold when compared to ZN control cells. G2/M blockage in ZS cells was coupled with 
enhanced p21 gene expression. In ZS cells, the abrogation of p21 protein induction by the 
transfection of p21 siRNA was shown to alleviate the G2/M blockage. A similar gene 
knock-down approach was used to establish if the p21 upregulation in ZS cells was p53 
dependent. Abolishment of the increase in p53 protein in ZS cells with transfection of 
p53 siRNA normalized the elevated p21 protein to a similar level as in ZN control cells, 
which demonstrated that the p21 induction is p53-dependent. Furthermore, the 
normalization of p53 protein by siRNA in ZS cells alleviated cell growth depression and 
G2/M blockage, which demonstrated that p53 was involved in the high zinc status 
induced G2/M blockage and growth depression. Thus, high zinc status in NHBE cells 
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Chapter I: Introduction 
Zinc is a structural component of a wide variety of functional proteins, enzymes, and 
transcriptional factors which is involved in a wide range of physiological processes such 
as growth, development, and functioning of the endocrine, immune, and nervous systems. 
Both epidemiological and experimental studies have reported positive association 
between dietary zinc deficiency and cancer diseases. Cell proliferation is induced by 
active cyclin/cdk (cyclin-dependence kinase) complexes. Cell cycle progression is 
impaired by the inhibition of cyclin/cdk complexes by cyclin kinase inhibitors (CKIs). 
p21 WAF1/Cip1, a member of the Cip/Kip family of CKIs, is capable of inhibiting the 
activity of cyclin/cdk complexes. DNA damage induces p21 overexpression, which leads 
to growth arrest at the G1 and G2 phase or S-phase.  Paradoxically, p21 stabilizes cyclin 
D1-cdk4/cdk6 assembly into active complexes, which modulate cell cycle positively. The 
role p21 as an assembly factor for cyclin D1-cdk4/cdk6 is completely opposite to its 
function as a cdk inhibitor. Repression of p21 depresses cyclin D1-cdk4/cdk6 complex 
formation and results in impaired cell cycle progression. Both p53-dependent and -
independent mechanisms are involved in transcriptional modulation of p21 expression. 
Two conserved p53-binding sites are located in the p21 promoter. After DNA damage, at 
least one of these is required for p53 responsiveness. The p53-independent activation of 
p21 transcription involves a variety of transcription factors which are induced by a 
number of different signaling pathways. 
 
In these studies, we have elected to induce zinc deficiency by using zinc depleted 
media (for HepG2 cells) and zinc-free basal BEGM medium (for Normal Human 
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Bronchial Epithelial cells) to examine the influence of zinc status on gene expression. 
Cells were cultured for one passage in a basal medium depleted of zinc to induce severe 
zinc-deficient (ZD) cells or in the basal medium supplemented with 0.4, 4.0, 16, or 32 
µM zinc to represent mild zinc deficiency (ZD0.4), the amount of zinc in most normal 
media (ZN), the normal human plasma zinc level (zinc-adequate, ZA), or the high end of 
plasma zinc attainable by oral supplementation (ZS), respectively..  
 
The transcriptional regulation of p21 gene in both human hepatoblastoma (HepG2) 
cells and normal human bronchial epithelial (NHBE) cells in response to different zinc 
status has been examined. These cells were selected because our preliminary data have 
shown marked reduction and enhancement in p21 mRNA expression, as well as 
depressed G1/S and G2/M cell cycle progression, in zinc-deficient HepG2 cells and zinc-
supplement NHBE cells, respectively. Thus, the effect of zinc on cellular proliferation 
was hypothesized to act through the manipulation of p21 pathway. The following 
approaches have been applied to test the hypothesis. Firstly, the effect of zinc status on 
p21 mRNA and protein levels was determined by RNase protection assay and Western 
blotting, respectively. Secondly, to determine if the p21 promoter was involved in this 
regulation, p21 promoter activity in response to different zinc status was measured by 
transient transfection of a p21-promoter-luciferase construct into cells. Moreover, the 
influence of zinc status on the modulation of p21 downstream components such as cdk-2 
that tightly regulates the cell-cycle progression was examined. Furthermore, the zinc-
effect on p21 transcription was studied for its relationship with p53. Finally, the gain of 
function approach using a p21 overexpressing plasmid and the loss of function approach 
involving siRNA technology were employed to investigate the physiological role of p21 
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related to cell cycle and growth proliferation in response to different zinc status. 
Experiments were designed to generate data to aid in the understanding of the influence 
of zinc status on cellular growth and proliferation as well as on the regulation of p21 



































1 Zinc Biology 
 
 
1.1 Zinc history and physiological function 
 The role of zinc as an essential trace mineral for humans was identified in 1960s 
(Prasad et al., 1984). Before that, the physiological function of zinc in humans was 
debatable. In 1934, the first in vivo study was performed to show that zinc deficiency 
caused poor growth and appetite loss in rats. In another in vivo study, swine fed the zinc 
inadequate diet showed serious side effects including parakeratosis. A few years later, 
detrimental effects of zinc deficiency in humans were also demonstrated to include 
stunted growth, poor reproductive development and suppressed immune function. Since 
then, detailed physiological function of zinc has been clearly elucidated. Zinc is an 
essential component of the catalytic site or sites of at least one enzyme in every enzyme 
classification (Salgueiro et al, 2000). The functions of numerous proteins in the body are 
supported by zinc. Among these proteins are the metalloenzymes, which are involved in a 
variety of metabolic processes. Zinc finger motif is an ubiquitous structure of most 
transcriptional factors. The configuration of these "zinc fingers," which directs their 
binding  to DNA, is determined by the single zinc atom. The binding of these zinc fingers 
to corresponding sites on  DNA initiates the transcription process and gene expression.
Similar motifs have been identified in nuclear hormonal receptors; including those for 




Table 1: Zinc functions in the organism 
Immune response onset and regulation 
Antioxidant 
Enzymatic cofactor 
Spermatogenesis and steroidgenesis 
Vitamin A metabolism 
Insulin storage and release 
Energetic metabolism 
Proteins synthesis 
Stabilization of macromolecules 
Regulaiton of the DNA transcription 
Cellular division 
Source: Salgueiro et al., 2000 
 
 
1.2 Sources of zinc 
Dietary zinc is mostly associated with the protein fraction of foods. Specifically, 
zinc is found in food, complexed with amino acids that are part of peptides and proteins 
as well as with nucleic acids. Table 2 shows zinc content of typical foods. The zinc 
content of these foods varies widely. Seafood and red meats are the two which contain 
plenty of zinc. Most vegetables also contain zinc, although in much lesser extent 
compared to seafood and red meats. Most U.S. mixed diets supply between 8.6 to 14 
mg/day of zinc; a relatively high amount due to the presence of zinc in animal protein 
(Sandstead and Smith 1996).  
 
1.3 Recommend Daily Allowance 




Table 2:  Zinc content of food  
 Mg of zinc/100g of food
 Meat 3.2 
Liver 5.1  
Egg 1.35 
 Milk 0.38 
Refined Cereals 0.50  
Whole wheat 1.00 
 Whole corn 2.50 
Whole rye 1.30 
 
Carobs 2.65 
Onion 1.40  
Peanut 2.00-3.00 
 Chocolate 1.00-2.00 
Fish and Shellfish 1.50  
Source: Salgueiro et al., 2000  
 
  
Table 3: Recommended dietary allowance  
Infants 3mg/day 
Children 1-3 years old 3mg/day  
Children 4.8 years old 5mg/day 
 Males 11mg/day 
Females 8mg/day  
Pregnant 11mg/day 





Lactating women 2nd semester 12mg/day 
Source: Dietary Reference Intake, Food and 
Nutrition Book, 2001 
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supplementation trials, have provided the evidence of zinc deficiency in several 
populations. The laboratory methods proposed to determine zinc status are: serum and 
plasma zinc concentrations, leukocyte and neutrophil zinc concentrations, the activity of 
selected enzymes such as 5’nucleotidase and lately, the erythrocyte metallothionein 
concentration. The major problem has been to find a reliable laboratory index of zinc 
status to estimate the individual zinc nutritional status, at the onset of zinc deficiency or 
zinc toxicity signs. Table 2 shows some of the zinc status indicators proposed (Grider and 
Young 1996). The lack of a reliable method to determine the zinc nutritional status also 
reflects the problem to estimate the RDA for zinc. Table 3 shows the recommendations 
proposed by the National Research Council. Nevertheless, more research is needed 
because of the difficulty in the application and interpretation of the usual methods to 
estimate the RDA, when trace metals are evaluated. 
 
1.3 Digestion, Absorption, Transport, Uptake, and Storage 
1.3.1 Digestion  
Before absorption of zinc is possible, zinc needs to be hydrolyzed from amino 
acids. Zinc is believed to be released from food during the digestive process in the 
stomach and small intestine. Proteases and nucleases in the stomach and small intestine 
play important roles. Hydrochloric acid also favors the digestion of protein to liberate the 
zinc from foods (Prasad 1984). 
1.3.2 Absorption 
Active and passive transport are two main mechanisms of zinc absorption in the 
mammalian small intestine. Active transport is saturable at high concentrations of the 
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zinc metal in the intestine lumen, and its efficiency increases during low intake periods. 
On the contrary, passive transport is a diffusion mechanism, which is inalterable during 
low intake periods and its efficiency is proportional to luminal zinc concentration 
(Cousins et al., 1986). Zinc absorption can be facilitated by activators. These are picolinic 
acid secreted by the pancreas, vitamin B6 that increases picolinic acid secretion, as well 
as citrate and aminoacids such as glycine, histidine, lysine, cystein and methionine 
(Sandstead et al., 1996; Evans et al., 1981). On the other hand, zinc absorption can also 
be impeded by inhibitors. These are phytic and oxalic acids, tannins, fiber, selenium, iron 
and calcium (Prasad 1984). Iron and calcium are debatable as inhibitors, but they appear 
to only interfere with zinc absorption at higher concentrations (Sandstead and smith 1996; 
Solomons and Jacob 1981; Wood et al., 1997). Zinc absorption efficiency is only 
between 15 to 40% of the amount of zinc ingested, the rest are excreted with the feces. 
There is also an endogenous zinc secretion into the intestinal lumen. This endogenous 
zinc comes from pancreatic, biliar and intestinal secretions as well as from desquamated 
mucosal cells (Sian et al., 1996; Berger and Schneeman 1986). Once in the intestine, both 
dietary and endogenous zinc are under the same homeostatic regulation, and they might 
be reabsorbed at distal segments of the intestine, or finally excreted with the feces. 
Homeostatic regulation of zinc is very important at the intestinal level. In order to 
maintain zinc homeostasis, during low zinc intake periods, there is a marked decrease of 
endogenous zinc secretion instead of an increase in zinc absorption (Sian et al., 1996). A 
more recent understanding is that the intestinal metallothionein is one of the proteins 
involved in this secretion process (Davis et al., 1998). Once zinc is absorbed, it may form 
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an intestinal pool bound to the intestinal metallothionein or it may be transported from 
the enterocyte to the blood. 
1.3.3 Transport 
Zinc transport in blood is mainly carried out by being complexed with albumin. 
Therefore, in conditions such as pregnancy and malnutrition, with low plasma albumin 
concentrations, zinc absorption decreases appreciably (Whitney et al., 1993). Other 
plasma components, such as α2-macroglobulin, transferrin, cystein and histidine, may 
also bind the metal. 
1.3.4 Metabolism 
Most of plasma zinc is bound to hepatic metallothionein and stored in liver. 
Methallothioneins are cytosolic proteins with high cystein content and they are the main 
proteins involved in zinc metabolism. These metalloproteins can bind seven atoms of 
zinc per molecule of protein, but they can also bind copper with higher affinity. 
Metallothionein isoforms 1 and 2 are highly expressed in liver, intestine, kidney and 
pancreas and their expression may be induced by many factors such as zinc rich diets, IL-
1 (Interleukin-1), IL-6, glucocorticoids, and stress, etc. Their biochemical roles are 
associated with heavy metal detoxification, scavenging of free radicals, and redistribution 
of body zinc in response to acute infection or stress. Hepatic metallothionein mainly 
appears to act as a zinc reservoir that may convey protection against zinc deficiency 
(Blain et al., 1998; Kelly et al., 1986). Intestinal metallothionein appears to act as a 




 A family of mammalian zinc transporters that plays an important role in the 
regulation of zinc metabolism at the intracellular level has been described. Zinc 
transporters such as ZnT-1 (Zinc Transporter), ZnT-2, Zn-T3 and ZnT-4 are zinc specific, 
while the divalent cation transporter-1 (DCT-1) is not zinc specific. The general structure 
of these zinc specific zinc transporters consist of 6 transmembrane domains, an 
intracellular histidine rich region and the amino and carboxyl terminus. ZnT-1 is widely 
expressed in the organism, and it functions as a zinc exporter. The direct regulation of the 
ZnT-1 gene by zinc was demonstrated in the mouse intestine and liver, independent of 
the level of metallothionein. ZnT-2 is expressed in intestine, kidneys and testes. It 
functions as a zinc exporter, but it has the capacity to compartmentalize zinc into 
intracellular vesicles. ZnT-3 expression is restricted to the brain, suggesting an important 
role for zinc in the central nervous system, and it is also expressed in testes. ZnT-3 
transporter activity is associated with vesicular packaging of zinc, and it could be 
involved in spermatogenesis and is related to insulin secretion. ZnT-4 is expressed in the 
mammary gland and the brain. A single point mutation in ZnT-4 gene resulting in a 
premature termination of the protein causes the lethal mouse syndrome. This syndrome is 
characterized by a marked decrease of zinc transport from the mammary gland to the 
milk (Davis et al., 1995; McMahon and Cousins 1998; Palmiter et al., 1996). 
 
1.4 Zinc deficiency 
1.4.1 Immune system 
Zinc is known to play a central and unique role in the immune system. 
Association of zinc deficiency and susceptibility to a variety of pathogens has been 
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widely reported (Palmiter et al., 1996; McMahon and Cousins 1998; Barone et al., 1998; 
Gyorffy et al., 1992). Clinical and experimental evidence showed that severe zinc 
deficiency causes thymus gland deterioration (McMahon and Cousins 1998; Chandra and 
Au 1980). This symptom may be explained in part by a raise of blood glucocorticoid 
concentration which reduces the number of circulating lymphocytes (Mocchegiani et al., 
1995; Shankar and Prasad et al., 1998; Good et al., 1980). Adverse effects of zinc 
deficiency on specific cells of the immune system include:  reduction in the number of 
lymphocytes in both central and peripheral lymphoid tissue; depression of the T and B 
lymphocyte function; and the decrease of proliferative responses to mitogens (Shankar 
and Prasad 1998; Prasad 1985; Prasad 1983; Shi et al., 1998). With regard to soluble 
mediators of immunity, zinc deficiency reduces thymulin activity and production or 
biological activity of multiple cytokines such as: IL-1, IL-2, IL3, IL4, IL-6, INF-γ, INF-α 
and TNF-α. Mild zinc deficiency also shows an imbalance of Th-1 cells and Th-2 cells 
function (Shankar and Prasad 1998; Lesourd et al., 1998; Saha et al., 1995). On the other 
hand, an adequate zinc status has been found to contribute to the preservation of the 
CD4:CD8 ratio, which prevents human immunodeficiency virus (HIV) infection for the 
transition to overt acquired immune deficiency syndrome (AIDS) (Sazawal et al., 1996; 
Shankar and Prasad 1998). Furthermore, zinc supplementation was widely reported to be 
able to reverse the immune defect symptoms caused by zinc deficiency (Shanka and 
Prasad 1998).  
1.4.2 Anorexia nervosa 
Zinc deficiency has been reported to be involved in the pathogenesis of anorexia 
nervosa. Animal studies showed that rats fed the zinc-deficient diet consumed 50% less 
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of total food intake compared with the rats fed the zinc-adequate diet. When these rats 
were forced fed, they became seriously ill and in some cases they died. However, upon 
zinc repletion, the rats recovered from the anorexia nervosa symptoms (Lee et al., 1998; 
Browning et al., 1998; Oner et al., 1984). The possible mechanism underlying anorexia 
nervosa onset was proposed to be related to a reduction in the synthesis of certain 
neurotransmitters by zinc deficiency. One of these neurotransmitter factors called 
neuropeptide Y (NPY), a potent appetite stimulant in the hypothalamus, was synthesized 
less in response to zinc deficiency (Browning et al., 1998). However, Lee et al. (1998) 
proposed that zinc deficiency may impair the processing of the NPY, which results in 
NPY with lower affinity for its receptors causing a decreased food intake (Lee et al., 
1998). 
1.4.3 Reproduction 
Zinc is necessary for the synthesis and secretion of luteinizing hormone (LH) and follicle 
stimulating hormone (FSH), gonadal differentiation, testicular growth, formation and 
maturation of spermatozoa, testicular sterioidogenesis and fertilization (Om and Chung 
1996; Madding et al., 1986). Zinc supplementation has been established to be beneficial 
in sterility and impotence in men and infertility in women. However, the mechanisms 
underlying these functions involved numerous zinc-dependent enzymes and the 
complexity of the complete pathway is not fully understood. Om and Chung (1996) 
reported that in zinc-deficient male rats, LH and testosterone concentrations were reduced, 
the hepatic steroid metabolism was altered and sex steroid hormones levels were 
modified (Om and Chung 1996). They concluded that zinc deficiency contributes to the 
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pathogenesis of male reproductive dysfunction such as infertility, hypogonadism and 
feminization (Om and Chung). 
1.4.4 Pregnancy 
Zinc deficiency has detrimental effects on many stages of pregnancy because many 
reproductive and developmental hormones are dependent on zinc for proper function. 
Several reports showed zinc deficiency to be associated with skeletal malformations, 
spontaneous abortion, prematurity or prolonged gestation and complication during 
delivery such as excessive loss of blood (Goldenberg et al., 1995; Hurley et al., 1983). 
The main teratogenic effects of zinc deficiency are related to neural tube defects in 
children of mothers with altered zinc status.  
1.4.5 Lactation and infancy 
Factors responsible for zinc deficiency in premature infants include high fecal losses of 
zinc in the newborn, low body stores of zinc at birth, increased zinc requirements during 
rapid growth, and also in a rare circumstance, a defect in transfer of zinc from maternal 
serum to breast milk (Prasad 1996). Zinc deficiency may be a common transient disorder 
in premature infants characterized by skin lesions resembling acrodermatitis 
enteropathica, diarrhea, and growth stunting and low weight for age (Piela et al., 1998; 
Folwaczny 1997). Potential benefits of maternal zinc supplementation to infants include 
enhancement of either quantity or quality of human milk and optimization of infant 
growth, development, and immune function. Favier (1992) found that supplementation of 
the food of breast-feeding mother with 15 mg zinc resulted in higher weight gain in their 
babies than in babies of control mothers (Favier 1992).  Clinical manifestations of zinc 












1.5 Zinc toxicity 
Table 4:  Zinc deficiency consequences 
Growth retardation Oligospermia 
Hypogonadism Weight loss 
Intercurrent infections Anorexia 
Altered immune response Diarrhea 
Increased absorption risk Alopecia 
Complications during delivery Mental lethargy 
Premature pregnancy Skin changes 
Neural tube defects of fetus Taste abnormalities 
Delayed wound healing Emotional disorders 
Abnormal dark adaptation Hyperammonaemia 
Source: Salgueiro et al., 2000  
 
High zinc concentration is well known to interfere with copper metabolism. 
Among patients with Wilson’s disease, zinc is the treatment of choice because high 
concentrations of zinc significantly limits the amount of copper absorbed, slowing the 
progression of the disease. Patients with acrodermatitis enteropathica need high doses of 
zinc to prevent zinc deficiency, but most of them develop copper deficiency (Grider and 
Young 1996). The hypothetical mechanism for zinc-copper interaction is related to their 
similar chemical and biochemical properties. Some authors proposed that the direct 
interference of zinc and copper occurs at the intestinal level. However, others suggest that 
high dietary zinc induces the increase of intestinal metallothionein which prevents copper 
absorption by binding to them with higher affinity (CastilloDuran et al., 1990; Sandstead 
1995). Acute toxicity studies showed that although multiple organs are exposed to zinc 
toxicity, the pancreas is the most affected, but the reason is not clear (Kelly et al., 1986; 
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Sutomo et al., 1992). The signs and symptoms that an acute oral zinc dose may provoke 
are: tachycardia, vascular shock, dyspeptic nausea, vomiting, diarrhea as well as 
pancreatic and hepatic parenchymal damage (Kelly et al., 1986). Nevertheless, the 
amounts of zinc that provoke toxic effects are much higher than those contained in 
regular diets, therefore, zinc toxicity is scarce. 
 
2. Zinc Deficiency and Cancer 
 
 
 Apart from the well established role of zinc in growth and development, 
reproduction, and immune function, available evidence indicates that zinc also exerts 
positive effect on genetic stability and function. Zinc is not only a component of more 
than 300 transcription factors that regulate expression of other genes. Enzymes including 
copper/zinc superoxide dismutase (CuZnSOD) and several proteins involved in DNA 
repair also require zinc as functional units (Prasad 1998; Prasad and Kucuk 2002; Prasad 
2003). Therefore, zinc may be implicated in cancer prevention by protecting genetic 
components from oxidation and damage. 
 
2.1 Zinc deficiency and oxidative stress 
 
Increased oxidant stress with low cellular zinc has been extensively reported. 
Increased oxidant production has been demonstrated in cells cultured in zinc-deficient 
media (Ho and Ames 2002). In an animal study, zinc-deficient rats showed increased 
oxidative protein and DNA damage (Taylor et al., 1988; Olin et al., 1993; Oteiza et al., 
1996). Moreover, zinc-deficient rats are more susceptible to oxidative injury. In addition, 
hyperoxic lung damage, carbon tetrachloride toxicity and lipid peroxidation have been 
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demonstrated in zinc-deficient rats when compared with zinc-adequate rats (Taylor et al., 
1988; Oteiza et al., 1996; Bray et al., 1986; Burke et al., 1987). In another approach, zinc 
supplementation has been shown to be beneficial against oxidant damage and the 
progression of ROS-induced diseases. For example, zinc supplementation has been 
established to protect against chemically induced models of Type 1 diabetes in CD1 mice 
(Ho et al., 2001; Mocchegiani et al., 2000). In another case, addition of zinc has been 
shown to protect human fibroblasts from UV-induced DNA damage and apoptosis 
(Leccia et al., 1999). Thus, the antioxidant role of zinc could be an important mechanism 
in maintaining DNA integrity in the cell and therefore preventing cancer development.  
 
2.2 Mechanism of zinc as an antioxidant 
 
Oxidative stress has been widely reported as an important contributor in several 
chronic degenerative diseases including cancer. Zinc deficiency can induce oxidative 
stress which may explain the mechanism by which zinc deficiency increases the risk for 
cancer development (Taylor et al., 1988). CuZnSOD is an important defense against 
reactive oxygen species, which are generated under both normal physiological 
metabolism and certain adverse conditions. The fact that zinc is an essential structure 
component of CuZnSOD and enables it to function properly in the removal of ROS, is 
one of the reasons why zinc is such an important antioxidant element (Prasad 1998; 
Prasad and Kucuk 2002; Prasad 2003).  The second possible mechanism for zinc’s 
antioxidant effect is that zinc can prevent hydroxyl radical formation by transition metals, 
such as iron or copper. Hydroxyl radicals (HO·) are powerful oxidizing species that can 
damage biological molecules, such as nuclei acid, significantly. HO· species are formed 
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by Fenton reaction when a single electron is transferred to H O2 2 from transition metals 
such as iron and copper. Zinc can prevent this reaction by acting as competitor for 
binding sites for pro-oxidant transition metals such as iron and copper (Kelly et al., 1986; 
Washabaugh and Collins 1986; Conte et al., 1996; Hesketh 1983; Fu et al., 1996).  
Although the magnificent role of zinc in maintaining DNA integrity and therefore 
preventing oxidative stress induced diseases, the pathology and disease development 
associated with oxidative stress may not be due simple to increases in oxidative damage 
(Datta et al., 2000). ROS may act as signaling molecules that trigger distinct pathways to 
induce pathology of disease. Thus, the role of zinc deficiency in the development of 
chronic disease, such as diabetes and cancer, may be far more complex than simply 
causing oxidative damage.  
 
2.3 Zinc and DNA repair 
 Besides an antioxidant role of zinc in maintaining DNA integrity, zinc also plays 
a critical role in the regulation of transcription and replication of DNA through zinc 
finger proteins. Zinc finger motif is an ubiquitous structure of most enzymes and 
transcriptional factors. Zinc atoms have specific structural roles in this motif. The 
 configuration of these "zinc fingers," which directs their binding to DNA, is determined 
by the single zinc atom. In fact, many DNA repair enzymes are zinc finger proteins and 
therefore require zinc to function properly. The well-known tumor suppressor protein p53 
is a zinc finger protein. p53 plays an important role in modulating cell cycle progression, 
apoptosis, DNA repair and cell proliferation/differentiation. p53 induces G1 arrest to 
allow the cell to repair damaged DNA before cellular division (Lane 1992). In fact, over 
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50% of human malignancies contain a mutation in p53 (Hollstein et al., 1991). The 
majority of these mutations are found in the region of the gene that distorts the DNA-
binding ability (Bedwal and Bahuguna 1994; Pavletich et al., 1993). This binding region 
also contains the zinc-binding domain. Increases in p53 protein expression accompanied 
with low intracellular zinc were demonstrated in several different cell lines (Ames 2001; 
Ho et al., 2003). Although the authors explained that the increases of p53 protein 
expression in response to low intracellular zinc is probably a mechanism to repair 
damaged DNA due to oxidative stress, p53 is likely dysfunctional to bind and activate 
downstream genes due to conformation alteration resulted from zinc deficiency. In fact, a 
marked decrease in the ability of p53 to bind to downstream DNA targets has been found 
in zinc deficiency (Ho and Ames 2002). Researchers have found that the removal of zinc, 
either by chemical chelation or by culturing in zinc-deficient media, alters the expression 
of p53 (Fanzo et al., 2001; Meplan et al., 2000). Direct chemical chelation also appears to 
reversibly alter p53 conformation, with the loss of DNA-binding activity (Hainaut and 
Hollstein 2000). In another case, low cellular zinc also increases the expression of 
apyrimidic endonuclease (APE) (Ho and Ames 2002). APE is an important endonuclease 
involved in base excision repair (Fritz 2000). In fact, APE levels appear to be elevated in 
a number of cancers (Thomson et al., 2000; Puglisi et al., 2002). Thus, the increased 
expression of APE in low cellular zinc cell line may probably be a response to DNA 
damage induced by low zinc (Ho and Ames 2002).  
 
2.4 Zinc deficiency, cell signaling and apoptosis 
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 Apoptosis is a process that cells undergo leading to programmed cell death. The 
induction of apoptosis is an important mechanism for the cell to “commit suicide” in 
response to DNA damage. Association of zinc deficiency and increased apoptosis in 
various cells and tissues has been reported. In one example, zinc deficiency markedly 
reduced lymphocyte numbers in both the thymus and marrow of zinc-deficient mice 
(Fraker et al., 1987). Increases in apoptosis are critical changes in lymphopoiesis and 
myelopoiesis in T and B cells with zinc deficiency (King and Fraker 2002). Zinc 
depletion has also been associated with caspase activation and increases in apoptosis in 
airway epithelial cells, lung and hepatocytes (Hennig et al., 1999; Truong-Tan et al., 2001; 
Nakatani et al., 2000). The possible mechanisms of zinc deficiency induced apoptosis 
include loss of zinc in critical proteins involved in the apoptotic cascade or undirected 
effects due to increased oxidative stress or a response to DNA damage. ROS are also 
known as inducers of apoptosis.  
 
2.5 Zinc deficiency and its relevance to cancer 
 The possible association of zinc deficiency and cancer has been established in 
humans, animals and cell culture systems. Lower zinc status has been observed in 
patients with cancer (Federico et al., 2001; Prasad et al., 1998). Zinc deficiency induced 
DNA damage and chromosome breaks have been reported in animals fed with a zinc-
deficient diet. In rats, dietary zinc deficiency causes an increased susceptibility to tumor 
development when exposed to carcinogenic compounds (Fong et al., 1996; Fong and 
Magee 1999). In the same animal model, zinc deficiency has been suggested to be a 
potential factor of esophageal tumors (Newberne et al., 1997). In vitro studies have also 
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shown that zinc deficiency can lead to increased oxidative damage to DNA of testicular 
cells (Oteiza et al. 1996). In the case of prostate cancer, zinc deficiency appears to play 
an important role, although the precise mechanism is unknown. Normal human prostate 
accumulates the highest levels of zinc. In contrast, a marked decrease in zinc content is 
associated with prostate cancer cell lines (Dhar et al., 1973; Platz and Helzlsouer 2001). 
A recent finding by Huang et al. (2006) demonstrated that tumorigenic prostate epithelial 
cells accumulated less intracellular zinc than non-tumorigenic prostate epithelial cells. 
Moreover, ZIP1 protein expression was lower in tumorigenic prostate epithelial cells. 
When ZIP1 gene was overexpressed in tumorigenic prostate epithelial cells, the cells not 
only demonstrated increase in intracellular zinc content but also showed suppressed 
tumor cell growth (Huang et al., 2006). Several studies have also shown that high cellular 
zinc levels inhibit prostate cancer cell growth (Costello et al., 1998; Feng et al., 2000; 
Uzzo et al., 2002). Although zinc supplementation has the potential to target multiple 
points of the carcinogenesis initiation, there exists controversy toward the efficacy of zinc 
supplements to prevent prostate cancer. An epidemiologic study showed an increase in 
risk for prostate cancer with high zinc supplement use (Leitzmann et al., 2003). Increased 
risk was seen in subjects with very high dose of over 100 mg/day zinc supplement or very 









The open reading frame of p53 is 393 amino acids long, with the central region 
(consisting of amino acids from about 100 to 300) containing the DNA-binding domain. 
This core is flanked by a C-terminal end mediating oligomerization and an N-terminal 
end containing a strong transcription activation signal. Initially, p53 was mistakenly 
described as an oncogene (Eliyahu et al., 1984) because the cloned p53 was a mutant 
form of wild type p53. The mutant form p53 used in transfection experiments contains a 
point mutation which activates their transforming properties. Further studies indicated 
that the wild type p53 protein has emerged as a key tumor suppressor protein at the 
crossroads of cellular stress response pathways. During their life, normal cells are 
constantly exposed to various endogenous and exogenous stresses that alter their normal 
behavior. Genetic insults that can lead to mutations are particularly harmful, as the cell’s 
transmission to daughters cells can lead to neoplasia. The p53 protein expression was 
found at very low levels in normal unstressed cells. After stress, different pathways lead 
to post-translational modification of the protein and its stabilization. This accumulation 
activates the transcription of a wide range of p53 downstream genes involved in various 
activities, including cell-cycle arrest, DNA repair, senescence, and apoptosis depending 
on the cellular context, the extent of damage or other unknown parameters (Bode et al., 
2004). Table 5 lists some examples of p53 downstream genes which are well studied. 
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Table 5 some examples of p53 downstream genes and its consensus binding sequences 
Gene Name Binding Sequence Gene Name Binding Sequence 
Apoptosis and survival Cell-cycle arrest and DNA repair 
Bax tcACAAGTTaAGACAAGCCT EGFR GAGCTAGaCgGGGCAgcCCC 
IGFBP3 AAACAAGCCacAACATGCTT Gadd45 GAACATGTCTAAGCATGCTg
 GGGCAAGaCCtGcCAAGCCT p21/WAF1 GAACATGTCCcAACATGTTg 
p53AIP1 tctCTTGCCCGGGCTTGTCg  GAAgAAGaCTGGGCATGTCT
KILLER/DR5 GGGCATGTCCGGGCAAGaCg p53R2 TGACATGCCCAGGCATGTCT
TGF-alpha GGGCAgGCCCtGcCTAGTCT 14-3-3-sigma GtAgcAtTagAGACATGTCC 
 AGcCAAGTCTtGGCAAGCgg BTG2/TIS21/PC3 AgtCcgGgCaAGcCcgagCa 
EE-lalpha GGGCAgaCCCGAGCATGCCC TGF-beta CAtCTTGCCCAGACTTGTCT 
 AAACATGaTTAGGgAcaTCT  AGcCATGCCCGGGCAAGaaC 
  PCNA GAACAAGTCCGGGCATaTgT
NOS3/ECNOS GAGCcTcCCaGGGCTTGTTC  AcAtATGCCCGGACTTGTTC 
DKK1 AGcCAAGCTTGAACcAGTTC   
LRDD AGGCcTGCCTGGACATGTCT   
Cathepsin D AAGCTgGgCCGGGCTgaCCC   
 AAcCTTGgTTcAAgAgGCTT   
BDKRB2 GGAagTGCCCAGGaggcTga   
P2XM GAACAAGggCGAGCTTGTCT   
    
Source: Shu et al., 2006 
3.2 p53 structure and functional domain 
 The human p53 protein consists of 393 amino acids; a complete three-
dimensional structure for entire p53 protein is not available. The full-length protein is 
difficult to crystallize or to be used in NMR studies due to the size (212 kDa) of its full-
length tetrameric form. However, the analyses on the p53 functional domains have 
greatly increased the understanding and knowledge we have about the structure of this 
protein and how it relates to the functions of p53. The p53 protein is commonly divided 
into three functional domains (Fig. 1). The acidic amino-terminal domain is required for 
transcriptional activation. MDM2 interacts with the N-terminal transactivation domain of 
p53 to inhibit p53 transcriptional activity. Most of the interactions between p53 and its 
downstream genes take place in the central core sequence-specific DNA binding domain 
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of p53 (Veprintsev et al., 2006; Ho et al., 2006). The carboxy-terminal end contains the 
tetramerization domain, which contains a nuclear export signal and nuclear localization 
signals, and the C-terminal regulatory domain. More than 20,000 mutations in the TP53 
gene have accrued in IARC (International Agency for Research on Cancer) TP53 
mutation database. TP53 predominantly shows missense mutations, in which the encoded 
protein contains amino acid substitutions. The missense mutation not only abrogates the 
tumor suppressive function, but also leads to the gain of oncogenic function by changing 
the repertoire of genes whose expression are controlled by this transcription factor 
(Dittmer et al., 1993; Hsiao et al., 1994).  
 






Source: Shu et al., 2006 
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3.3 p53 pathway 
 The p53 pathway is composed of p53 gene and a network of its downstream genes 
that are targeted to respond to a variety of intrinsic and extrinsic stress signals, which 
impact upon cellular homeostatic mechanisms that monitor DNA replication, 
chromosome segregation and cell division (Shu et al., 2006). Having a short half-life, p53 
is normally maintained at low levels in unstressed mammalian cells. When the cell is 
confronted with stress, however, p53 ubiquitylation is suppressed and p53 is stabilized 
and accumulates in the nucleus, where it forms a homotetrameric complex. Only 
tetrameric p53 seems to be fully active as a transcriptional activator or repressor of p53 
downstream genes that contain p53 sequence-specific DNA binding sites. The widely 







Source: Shu et al. 2006  
Figure 2. p53 is a key molecular node in the cellular stress pathways 
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3.3.1 Growth arrest 
 p21WAF1/CIP1 is known to be a p53-downstream gene, and has been suggested to 
mediate p53-induced growth arrest triggered by DNA damage. The p21 protein is a 
cycline-dependent kinase inhibitor of cyclin dependent kinase 2 (CDK2). After CDK2 
kinase activity is inhibited by p21, pRB is dephosphorylated and associated with 
transcriptional factor E2F, which finally leads to cell cycle arrest at G1. As long as pRb is 
bound to E2F, the cell is prevented from entering into S phase. This G1 arrest affords the 
cell time to repair the DNA damage. Should repair be unsuccessful, p53 levels drop and 
CDK-cyclin protein kinase activity resumes, which leads to entry into S phase. In the 
event that the DNA is not repair, p53 triggers apoptosis (Kim and Zhao 2005). 
3.3.2 DNA repair 
 The p53 tumor suppressor gene plays an important role in the maintenance of 
genomic stability, and DNA repair is a major factor in maintaining genomic stability 
(Avkin et al., 2006; Nowak et al., 2002; Liu et al., 2005). Therefore, p53 mediated DNA 
repair may play an essential role in the maintenance of genomic stability. p53 has been 
shown to be involved in various types of DNA repair, including nucleotide excision 
repair (NER), base excision repair (BER), nonhomologous end-joining (NHEJ) and 
homologous recombination (HR) (Smith et al., 2002; Bertrand et al., 2004) (Table 2). 
p53-dependent transcriptional activity is important for the regulation of NER by 
p53 (Adimoolam et al., 2002). p53 binds to and modulates the activities of the NER-
associated helicases XPB, XPD (Wang et al., 1997), regulates the expression of the 
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DDB2 and XPC (Hwang et al., 1999; Adimoolam and Ford 2002; Rubbi and Milner 
2003), and serves as a chromatin accessibility factor for NER of DNA damage (Wang et 
al., 1997). BER is mediated by at least two pathways: a ‘short-patch-repair’ pathway, 
which involves the repair of a single nucleotide, and a ‘long-patch-repair’ pathway, 
which involves repairing 2–15 nucleotides (Hoeijmakers 2001). In mammalian cells, 
most DNA double-strand breaks (DSBs) are repaired by NHEJ (Lieber et al., 2003). 
NHEJ is carried out by the combined action of different proteins, including DNA-PK 
(DNA-dependent protein kinase), XRCC4 (X-ray repair complementing defective repair 
in Chinese hamster cells-4) and DNA ligase IV (LIG4). However, other studies indicated 
that the p53-mediated apoptotic response is intact, even in the absence of DNA-PK 
(Sengupta and Harris 2005). p53 can physically bind to RAD51 and RAD54, major 
components of HR machinery, and controls the level of HR (Sengupta et al., 2003). 
Mutation in the WTp53 hotspot codon 273 reduces the capacity of p53 protein to bind 
with RAD51-DNA complexes (Susse et al., 2000). 
3.3.3 Apoptosis 
 The role of p53 in apoptosis has been studied extensively and linked to its tumor 
suppressor activity (Yee et al., 2005). In response to cellular stress, p53 transactivates or 
transrepresses many different downstream genes to trigger apoptotic responses. The p53-
mediated transactivation of apoptosis-related genes includes proapoptotic Bcl-2 family 
members, apoptotic protease activating factor-1 and Fas/CD95, death receptor 4. In 
addition to the mechanism involving p53-dependent transactivation of apoptotic genes, 
transcription independent mechanisms have also been suggested in p53-mediated 
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apoptosis (Haupt et al., 2003). p53 can also directly bind to and inhibit the Bcl-XL and 
Bcl2 proteins, leading to the release of cytochrome C (Mihara et al., 2003) and the 
initiation of the caspase cascade. There is strong evidence suggesting PUMA as a critical 
component of p53-mediated apoptosis, and in other cell types, NOXA seems to be 




 Using a subtractive hybridization approach, El-Deiry et al. (1995) identified a 
gene they called WAF1 (for wildtype p53-activated fragment 1), whose induction was 
associated with wildtype but not mutant p53 gene expression in a human brain tumor cell 
line. El-Deiry et al. (1995) found that the sequence, structure, and activation by p53 was 
conserved in rodents. Transfection of WAF1 cDNA suppressed the growth of human 
brain, lung, and colon tumor cells in culture. Using a yeast enhancer trap, they identified 
a p53-binding site 2.4 kb upstream of WAF1 coding sequences. The WAF1 promoter, 
including this p53-binding site, conferred p53-dependent inducibility upon a heterologous 
reporter gene. WAF1 is commonly named as p21 indicating its protein size of 21kD. 
 
4.2 p53 dependent regulation of p21 gene function 
 The tumor suppressor protein p53, a nuclear protein, plays an essential role in the 
regulation of cell cycle, specifically in the transition from G0 to G1. It is found in very 
low levels in normal cells. However, in a variety of transformed cell lines, it is expressed 
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in high amounts, and is believed to contribute to transformation and malignancy (Wiman 
1997). Mutants of p53 that frequently occur in a number of different human cancers fail 
to bind the consensus DNA binding site, and hence cause the loss of tumor suppressor 
activity (Wiman 1997). Sequence comparision of the rat, mouse, and human p21 
promoter sequences revealed conservation of two p53-responsive elements in these 
promoters (El-Deiry et al., 1995). Therefore, p53 is a major regulator of p21 
transcriptional activity through the p53-dependent pathway.  After gamma-irradiation 
induced DNA damage, p53 transactivates p21 expression through the binding to at least 
one of p53-responsive elements (El-Deiry et al., 1995). Irradiation of human cell lines 
also leads to p53-dependent cell cycle arrest at G1 (Dulic et al., 1994; Namba et al., 
1995). Mouse embryonic fibroblasts which are deficient in both copy of p21 alleles 
exhibit impaired ability to undergo G1 arrest in response to DNA damage (Deng et al., 
1995; Brugarolas et al., 1995).  A study using CHIP assay indicated that the activation 
domains, the proline-rich domain, and the C-terminal basic domain in p53 are necessary 
for acetylation of histones on the proximal p21 promoter and for interaction with 
p300/CREB-binding protein (Liu, et al., 2003). In this study, the down-regulation of 
p300/CBP by short interference RNA (siRNA), markedly decreases the ability of p53 to 
induce endogenous p21, and therefore demonstrated the importance of p300/CBP in p53-
dependent regulation of p21 expression. In addition, another study has demonstrated that 
p53 cooperates with the transcription factor Sp1 in the activation of the p21 promoter, 
whereas histone deacetylase 1 (HDAC1) counteracts p53-induced transcription of the p21 
gene (Lagger et al., 2003). To localize the tumor suppression function within the structure 
of p21, Zakut and Givol (1995) used vectors constructed with systematic truncations of 
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p21 and tested their efficiency in suppressing tumor cell growth. They demonstrated that 
the N-terminal half of the p21 molecule shows better tumor cell growth suppression than 
the entire p21 molecular, whereas the C-terminal half of p21 did not show this effect. 
After DNA damage, many cells appear to enter a sustained arrest in the G2 phase of the 
cell cycle. Bunz et al. (1998) demonstrated that this arrest could be sustained only when 
p53 was present in the cell and capable of transcriptionally activating the cyclin-
dependent inhibitor p21. After disruption of either p53 or the p21 gene, gamma-radiated 
cells progressed into mitosis and exhibited a G2 DNA content only because of a failure of 
cytokinesis. Thus, p53 and p21 appear to be essential for maintaining the G2 Checkpoint 
in human cells.  
4.3 p53 independent regulation of p21 
 Apart from p53-dependent regulation, a variety of factors have been found to 
activate p21 transcription in a p53-independent pathway. Several of these factors are 
discussed below. Sp1 is a member of a multigene family that binds DNA through C-
terminal zinc-finger motifs (Kennett et al., 1997). Six Sp1 binding sites, that span the 
region between -119 bp and transcription start site of p21 promoter, play a major role in 
the regulation of p21 transcription. Sp1 transcriptional factor mediates induction of the 
p21 gene through Sp1-1 and Sp1-2 sites in response to phorbol ester and okadaic acid in 
human leukemic cells undergoing differentiation toward macrophoages (Biggs et al., 
1996). The tumor-suppressor protein BRCA1 transactivates p21 in a p53-independent 
fashion via the region from -143 to -93 bp, which contains the Sp1-1 and Sp1-2 sites 
(Somasundaram et al., 1997). Many other agents such as transforming growth factor-β, 
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2+Ca  and butyrate have also been shown to require Sp1 site to induce p21 transcription 
(Datto et al., 1995; Prowse et al., 1997; Nakano et al., 1997). Interaction of Sp1 with 
Smad proteins mediates induction of the p21 promoter by transforming growth factor-β. 
Calcium induces p21 promoter through only Sp3 site in keratinocytes. In butyrate treated 
cells, the binding of Sp1 to Sp1 site of p21 promoter is involved in the induction of p21 
(Lee et al., 1998). The transcriptional coactivators p300/CBP can cooperate with Sp1 
and/or Sp3 to induce expression from the p21 promoter. Through the regulation of p300 
transcriptional coactivator activity, nerve growth factor (NGF) is able to induce neuronal 
differentiation and p21 expression in PC12 cells (Yan et al., 1997; Billon et al., 1996).  
Many other transcriptional factors such as AP2, E2Fs, STATs, C/EBPα, C/EBPβ, and the 
homeobox transcription factor gax can also induce p21 transcription in response to 
different signals. Some of these are discussed below. The p21 promoter is transactivated 
via an activator protein 2 (AP2) consensus binding site located between -103 and -95 bp. 
AP2 induced p21 transcription and growth arrest after treatment of cells with phorbol 
ester (Zeng et al., 1997). E2F1 and E2F3 strongly transactivate p21 transcription through 
cis-acting elements located between nucleotides -119 to +16 of the p21 promote (Gartel 
and Tyner, 1999; Hiyama et al., 1998). EGF and IFN-γ have been shown to induce cell 
growth arrest and upregulation of the p21 promoter by STAT1 via three STAT binding 
sites, which are located at -690, -2590, and -4233 bp in the p21 promoter (Chin et al., 
1996). Overexpression of gax in vascular smooth muscle cells and fibroblasts induced 
cell growth arrest via p53-independent upregulation of p21 by unknown mechanism 
(Chinery et al., 1997). Hikasa et al. (2003) found p21 downregulation in conjunction with 
c-fos regulation in the lymphocytes of patients with rheumatoid arthritis. Phosphorylation 
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of STAT1 was also decreased in rheumatoid arthritis lymphoctes. Hikasa et al. (2003) 
determined that c-fos overexpression led to reduced phosphorylation and dimerization of 
STAT1, which in turn downregulated p21 gene expression. They concluded that this 
regulatory pathway may enhance the proliferation of lymphocytes in rheumatoid arthritis 
patients. By electrophorectic mobility shift assays, Nakatani et al. (2003) found that 
EWS-FLI1 interacted with the ETS consensus sequence within the promoter region of the 
p21(WAF1) gene. Reporter gene assays indicated that the binding of WES-FLI1 to at 
least 2 ETS-binding sites negatively regulated p21(WAF1) promoter activity. WES-FLI1 
also suppressed p21(WAF1) induction by interacting with p300 and inhibiting its histone 
acetyltrasferase activity. Asada et al. (2004) determined that p21 interacts directly with 
BRAP in vitro and in vivo, and the interaction requires the C-terminal portion of BRAP 
and the nuclear localization signal of p21. When cotransfected with BRAP, p21 was 
expressed in the cytoplasm. Monocyte differentiation of promyelomonocytic cell lines 
was associated with upregulation of BRAP expression concomitantly with upregulation 
and cytoplasmic relocalization of p21. Asada et al. (2004) concluded that BRAP plays a 
role in the cytoplasmic translocation of p21 during monocyte differentiation. Carreira et 
al. (2005) showed that MITF can act as a novel antiproliferative transcription factor able 
to induce a G1 cell cycle arrest that is dependent on MITF-mediated activation of the p21 
cyclin-dependent kinase inhibitor gene. Moreover, cooperation between MITF and the 
retinoblastoma protein RB1 potentiates the ability of MITF to activate transcription. 
Carreira et al. (2005) suggested that MITF-mediated activation of p21 expression and the 
consequent hypophosphorylation of RB1 contribute to cell cycle exit and activation of the 
differentiation program. Rangarajan et al. (2001) found that Notch1 activation induced 
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p21 in differentiating mouse keratinocytes, and the induction was associated with the 
targeting of the p21 promoter. Mammucari et al. (2005) showed that Notch1 also 
activated p21 through a calcineurin-dependent mechanism by acting on the p21 TATA 
box-proximal region. Notch signaling through the calcineurin/NFAT pathway also 
involved calcipressin and Hes1. Zhang et al. (2007) noted that hematopoietic stem cells 
are resistant to human immunodeficiency virus (HIV)-1 infection, despite of the presence 
of CD4 and CXCR4, which are involved in viral entry. They found that small interfering 
RNA-mediated knockdown of p21, but not other CDK inhibitors, altered HIV-1 infection, 
enhanced HIV-1 replication, and increased HIV-1 integration prior to changes in cell 
cycling and without altering CD4 and CXCR4 surface expression. 
Coimmunoprecipitation and Western blot analyses showed that p21 interacted with the 
HIV-1 integration machinery and appeared to inhibit the ability of HIV-1 to integrate into 
cellular DNA. Silencing of p21 had no effect on expression of other mediators of 
resistance to HIV-1 infection.  Zhang et al. (2007) concluded that p21 is an endogenous 
cellular component in stem cells that provides a molecular barrier to HIV-1 infection. 
Figure 3 shows p21 proximal and distal p21 promoter with p53-dependent and –
independent binding elements. 
4.4 The consequence of p21 repression is not always promoting cell proliferation  
 In the majority of cases, the repression of p21 released its inhibition of 
cyclin/cdk2 complexes activity and resulted in enhanced cell cycle progression. In this 
context, p21 acts as an inhibitor of cyclin/cdk2 complexes. However, p21 can function as 
an assembly factor for cyclin D-cdk4/cdk6 and modulate the complex activity in a 
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concentration dependent manner. At low and intermediate concentrations, p21 stabilizes 
cyclin D-cdk4/cdk6 assembly into active complexes and modulate cell cycle positively 
(LaBaer et al., 1997). p21 repression in this context understandably impairs cell cycle 
progression by reducing cyclin D-cdk4/cdk6 formation and this has been demonstrated in 
several reports. In smooth muscle cells, Sp1 repression of p21 transcription mediated by 
Sp1 binding sites in the proximal promoter, reduces formation of cyclin D-cdk4-p21 
complex, whose integrity is essential for G1/S transition, and subsequently inhibited cell 
growth (Kavurma & Khachigian 2003). Moreover, in endothelial cells, the Notch 
pathway mediated p21 repression, decreased cyclin D-cdk4 formation and nuclear 
targeting, which lead to a reduced retinoblastoma protein phosphorylation as well as a 
depressed S-phase entry and cell cycle progression (Noseda et al., 2004). Thus, p21 
repression may not always lead to growth promotion. Furthermore, treatment of LoVo 
colon cancer cells with anticancer camptothecin represses p21 expression and sensitizes 
the tumor cells to apoptosis. Similarly, chemical inhibitors, such a triptolide (Chang et al., 
2001) and mithramycin A (Koutsodontis & Kardassis, 2004), which repress p21, have 

























Zinc deficiency depresses p21 gene expression: Inhibition of cell cycle progression is 
independent of the decrease in p21 protein level in HepG2 cells 
 
ABSTRACT 
The influence of zinc status on p21 gene expression was examined in human 
hepatoblastoma (HepG2) cells. Cells were cultured for one passage in a basal medium 
depleted of zinc to induce severe zinc-deficient (ZD) cells or in the basal medium 
supplemented with 0.4, 4.0, 16, or 32 CM zinc to represent mild zinc deficiency (ZD0.4), 
the amount of zinc in most normal media (ZN), the normal human plasma zinc level 
(zinc-adequate, ZA), or the high end of plasma zinc attainable by oral supplementation 
(ZS), respectively. In ZD and ZD0.4 cells, the nuclear p21 protein level, mRNA 
abundance and promoter activity were reduced to 40%, 70%, and 65%, respectively, of 
ZN cells. However, p21 protein and mRNA levels as well as p21 promoter activity were 
not altered in ZA and ZS cells as compared to ZN cells. Moreover, the amounts of 
acetylated histone 4 associated with the proximal and distal p21 promoter regions, as a 
measure of p21 promoter accessibility, were decreased in ZD (73 and 64 %, respectively) 
and ZD0.4 (82 and 77 %, respectively) cells than in ZN cells (100 and 100 %, 
respectively). Thus, multiple lines of evidence indicate that the transcriptional process of 
p21 is down-regulated by depressed zinc status in HepG2 cells. Furthermore, the 
transfection of 5Cg of PCMV-p21 plasmid, which constitutively expressed p21, was able 
to normalize the reduction in p21 protein level and cyclin D1- cdk4 complex activity but 
not the inhibition of cell growth and G1/S cell cycle progression in ZD cells. 
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INTRODUCTION 
Cell proliferation is induced by active cyclin/cdk (cyclin-dependence kinase) 
complexes. Cell cycle progression is impaired by the inhibition of cyclin/cdk complexes 
by cyclin kinase inhibitors (CKIs). p21 WAF1/Cip1, a member of the Cip/Kip family of CKIs 
(El-Deiry et al., 1993; Xiong et al., 1993), is capable of inhibiting the activity of 
cyclin/cdk complexes. DNA damage induces p21 overexpression, which leads to growth 
arrest at the G1 and G2 phase (Niculescu et al., 1998) or S-phase (Ogryzko et al., 1997). 
Cellular p21 level is modulated by various mechanisms: transcriptional regulation; 
epigenetic silencing; mRNA stability; as well as ubiquitin-dependent and -independent 
protein degradation. p21 is a short-lived protein and proteasome inhibition leads to an 
increase in p21 protein levels and in p21 half-life (Maki and Howley 1997; Sheaff et al., 
2000). Basal turnover of p21 controlled by the proteosome does not appear to require 
ubiquitination (Bendjennat et al., 2003), although a role for N-terminal ubiquitination of 
p21 has been proposed (Bloom et al., 1991). Thus, p21 expression may be regulated 
posttranslationally by both ubiquitin-dependent and –independent proteasome-mediated 
degradation (Maki and Howley 1997; Smirnova 2000). Moreover, p21 protein levels 
have been reported to be regulated by posttranslational modifications such as 
phosphorylation (Li et al., 2002).  
 
As for the transcriptional modulation of p21 expression, both p53-dependent and -
independent mechanisms are involved. Two conserved p53-binding sites are located in 
the p21 promoter. After DNA damage, at least one of these is required for p53 
responsiveness (El-Deiry et al., 1995). The p53-independent activation of p21 
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transcription involves a variety of transcription factors, including Sp1, Sp3, Ap2, STATs, 
C/EBP , C/EBPβ, and the bHLH proteins BETA2 and MyoD, which are induced by a 
number of different signaling pathways (Gartel and Tyner 1999). Six conserved Sp1 
binding sites 126 are located in the proximal promoter of the human p21 gene. Within the 
p21 promoter, the Sp1 site between -87 and -72 from the start site appeared to be 
essential for the activation of the p21 promoter by HDAC inhibitors (Huang et al., 2000). 
 
Paradoxically, p21 stabilizes cyclin D1-cdk4/cdk6 assembly into active 
complexes, which modulate cell cycle positively (LaBaer et al., 1997). The role p21 as an 
assembly factor for cyclin D1-cdk4/cdk6 is completely opposite to its function as a cdk 
inhibitor. Repression of p21 depresses cyclin D1-cdk4/cdk6 complex formation and 
results in impaired cell cycle progression. In smooth muscle cells, Sp1 repression of p21 
transcription mediated by Sp1 binding sites in the proximal p21 promoter, reduced 
formation of cyclin D1-cdk4/cdk6-p21 complex, whose integrity is essential for G1/S 
transition, and subsequently inhibited cell growth (Kavurma and Khachigian 2003; 
Kavurma and Khachigian 2004). Moreover, in endothelial cells, the Notch pathway 
mediated p21 repression, decreased cyclin D1-cdk4 formation and nuclear targeting, 
which lead to a reduced retinoblastoma protein phosphorylation as well as a depressed S-
phrase entry and cell cycle progression (Noseda et al., 2004). Thus, p21 repression may 
also lead to depressed cell cycle progression.  
 
Reductions of zinc status may promote apoptosis in certain cell type (Fraker and 
Telford 1997) and depressed G1/S cell cycle progression in HepG2 cells (Cui et al., 
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2002). In studies using membrane permeable chelator to induce severe zinc deficiency, 
zinc has been shown to play a structural role in p53 and is essential for its DNA binding 
activity as well as its stability. However, membrane permeable chelators may induce 
unknown side effects as well as extremely severe deficiency not achievable by dietary 
depletion. Thus, we have elected to induce zinc deficiency by using low zinc or zinc 
depleted media, without culturing cells with membrane permeable chelators, to examine 
the influence of zinc status on gene expression. Cells were cultured for one passage in a 
basal medium depleted of zinc to induce severe zinc-deficient (ZD) cells or in the basal 
medium supplemented with 0.4, 4.0, 16, or 32 µM zinc to represent mild zinc deficiency 
(ZD0.4), the amount of zinc in most normal media (ZN), the normal human plasma zinc 
level (zinc-adequate, ZA), or the high end of plasma zinc attainable by oral 
supplementation (ZS), respectively. Reductions in cellular zinc are at the same magnitude 
as observed in tissue zinc seen in animals fed zinc-deficient diets and are much less 
severe than the use of membrane permeable chelators. Compared with ZN cells, both p53 
mRNA and nuclear protein abundance were first reported to be increased 2-fold in ZD 
cells and normalized by culturing ZD cells in ZA medium in the last 24 hours in HepG2 
cells by Reaves et al., (Reaves et al., 2000). By using a low zinc growth medium (ZD), 
nuclear p53 protein levels were increased about 5-fold and 2-fold in ZD cells than that in 
ZN cells of the normal human bronchial endothelial (NHBE) and normal human aortic 
endothelial (HAECs) cells, respectively. p53 mRNA level was increased 2.5-fold in ZD 
cells than that of ZN NHBE cells and it was too low to be quantitated in HAECs cells 
(Fanzo et al., 2002; Fanzo et al., 2001). Our first observation that p21 mRNA was not up 
regulated in the presence of p53 nuclear accumulation was seen in the ZD NHBE cells. 
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Moreover, in HAECs, although there was no significant difference for p21 mRNA 
abundance between ZD and ZN cells, there was a trend of 20% reduction in ZD cells.  
 
The present study was designed to test the hypothesis that zinc deficiency would 
repress the expression of p21 mRNA and nuclear protein, as well as the p21 promoter 
accessibility and activity in HepG2 cells. In addition, the hypothesis that in zinc-deficient 
HepG2 cells, the impaired cell growth and G1/S cell cycle progression is independent of 
the depressed p21 expression was also examined. The reasons for using HepG2 
hepatoblastoma cells for the current study are as follow: a). Normal human hepatocytes 
do not divide and the cost for their usage would be financially impractical; b). HepG2 
hepatoblastoma cells will grow for many passages in serum-containing medium of 
various zinc status to provide sufficient quantities of cells for needed assays; c). HepG2 
cells are known to have normal p21 and p53 genes as well as they have been used for 
studying p21, p53, and signal transduction pathways; d). HepG2 cells response well in 
the serum-containing culture system with different zinc status and they do not require the 
expensive serum-free medium required for normal human cells in primary culture; and e). 
The zinc depleted medium for HepG2 cell culture is lower in zinc than those used for 
HAECs and NHBE cells and can induce a more severe zinc-deficient state. 
 
 
MATERIALS AND METHODS 
Cell Culture and Treatment -- The human hepatoblastoma cell line, HepG2, was 
purchased from the American Type Culture Collection (Manassas, VA). Chelex100 ion 
exchange resin (Bio-Rad, Hercules, CA) was used to deplete zinc from FBS before FBS 
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was added to DMEM (Reaves et al., 2000). The resin was first neutralized to 
physiological pH with 0.25 M HEPES, pH 7.4, and then mixed with FBS in a 1:4 ratio at 
4°C for 2 h. The Chelex100 resin was separated from FBS by centrifugation, followed by 
filtration through a 0.4-μm filter for sterilization and removal of residual Chelex100 resin. 
The zinc concentration in this chelexed FBS was < 1.0 µM, as determined by flame 
atomic absorption spectrophotometry (Hitachi, San Jose, CA). The basal medium 
consisted of DMEM with 10% chelexed FBS, containing <0.1 µM zinc, was termed the 
zinc- deficient (ZD) medium. For the other treatment groups, zinc was added to the media 
in the form of ZnSO4 so the only difference between these media was the zinc 
concentration. The ZD0.4 medium was prepared by addition of 0.4 µM ZnSO4 to ZD 
medium. Previous studies have shown that addition of at least 0.4 µM ZnSO4 to ZD 
medium is required to prevent marked depression of HepG2 cell growth observed in 
severe zinc deficiency. The zinc normal (ZN) and the zinc-adequate (ZA) media were 
prepared by adding 4.0 and 16.0 µM ZnSO4 to ZD medium to mimic the zinc level 
observed in normal culture medium or in human plasma, respectively. The zinc-
supplemented (ZS) medium consisted of the ZD medium plus 32 µM ZnSO4 was used to 
represent plasma zinc level attainable by oral zinc supplementation in humans. The 
HepG2 cells were cultured overnight in ZN medium before being changed to their 
respective media. Cells were then cultured in ZD, ZD0.4, ZN, ZA, or ZS media for the 
time period as indicated. In experiments with the rescue treatment, cells were cultured in 
ZD medium for 4 days and then switched over to ZS medium for the last 2 days of 
culture prior to being harvested as ZD+32μM cells. 
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Determination of Cell number and Viability as well as Cellular Zinc Levels -- Cells 
and media were collected from tissue culture plates. Cell number was measured by using 
a hemocytometer. Cell viability was assessed by the traditional Trypan Blue assay. In 
addition, nonviable cell counts were also determined by the NucleoCounter using the 
NucleoCassette Kit and NucleoView software (ChemoMetec A/S, Allerd, Demark), 
according to the manufacturer protocol. The system features an integrated fluorescence 
microscope designed to detect signals from a fluorescent dye, propidium iodide, which 
intercalate to DNA in the nuclei of nonviable cells. Moreover, cell pellets, resulting from 
centrifugation at 200 x g for 2 min at 4 C, were washed twice with phosphate　 -buffered 
saline (PBS), resuspended in 1.5 mL PBS, and sonicated. Cellular zinc content was 
measured by flame atomic absorption spectrophotometry (Model 5000, Perkin Elmer, 
Norwalk, CT) by using standard curves of 0.05-1.0 ppm generated with certified zinc 
reference solutions (Fisher Scientific, Fair Lawn, NJ) as previously described (Reaves et 
al., 2000). Furthermore, the certified zinc solutions were compared to Bovine Liver 
Standard Reference (U.S. Department of Commerce, National Institute of Standards, 
Gaithersburg, MD). Appropriate blanks were employed for all measurements. Cellular 
zinc was calculated as ng per million cells and presented as % of ZN cells. 
 
Nuclear and Cytoplasmic Extract Preparation -- The NE-PER Nuclear and 
Cytoplasmic Extraction Reagents and the Halt Protease Inhibitor Cocktail Kits (Pierce 
Biotechnology, Rockford, IL) were used for nuclear and cytoplasmic extracts preparation 
according to the manufacturer’s instructions, which are based on the method of Smirnova 
et al. (Smirnova 2000). Nuclear and cytoplasmic extracts were then stored in aliquots at -
80 C　 . Protein concentrations were determined by using the BCA Protein Assay Reagent 
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kit (Pierce). Contaminations of nuclear extracts by cytoplasmic proteins or contamination 
of cytoplasmic extracts by nuclear proteins, detected by Western blot analysis of Hsp90 
or Oct-1, respectively, were routinely found to be less than 5% in our lab. 
 
Western Blot Analysis -- Forty µg of nuclear and cytoplasmic protein were resolved on 
a 10% SDS-polyacrylamide gel electrophoresis and transferred to Hybond ECL 
nitrocellulose membrane (Amersham Pharmacia Biotech, Piscataway, NJ) by using a 
mini-transfer system (Bio-Rad, Hercules, CA). Membranes were blocked with 5% nonfat 
dry milk in PBS-T (10mM phosphate buffer pH7.3, 137mM NaCl, 2.7mM KCL, and 
0.1% Tween 20) for 1 h at room temperature, prior to incubation with 1 µg/ml of a rabbit 
anti-p21 polyclonal antibody (C-19) from Santa Cruz Biotechnology (Santa Cruz, CA), in 
PBS-T containing 5% nonfat milk at 4 °C overnight. Membrane was then washed three 
times with PBS-T and blotted with a secondary antibody conjugated with horseradish 
peroxidase (Santa Cruz) at room temperature for 1 h, followed by three washes in PBS-T. 
The protein was visualized by using the Western Blot Luminol Reagent (Santa Cruz 
Biotechnology) and exposed to film. The optical densities of the protein bands were 
quantified by the Alpha Innotech Imaging System (San Leandro, CA). 
 
RNase Protection Assays (RPA) -- Total cellular RNA was isolated from HepG2 cells, 
using the RNeasy Mini Kit (Qiagen, Valencia, CA), according to manufacturer’s 
instructions. The integrity of the RNA was verified by RNA gel electrophoresis. The 
mRNA abundance of p21 was measured by the non-radioactive RNase Protection Assay 
System (BD Biosciences, San Diego, CA), according to manufacturer’s instructions. The 
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human GAPDH probe was used as internal reference for normalization. Biotin-labeled 
riboprobes were synthesized using non-Rad In Vitro Transcription kit with T7 RNA 
polymerase (BD Biosciences) according to manufacturer’s instructions.  
 
p21 Promoter Activity -- The influence of zinc status on the human p21 gene promoter 
activity was studied by transient transfection of a p21-promoter-luciferase gene into Hep 
G2 cells. This approach was used to provide further evidence that the transcription 
process is depressed by a reduction in p21 gene promoter activity in zinc-deficient Hep 
G2 cells. 
 
Preparation of Luciferase Construct. The p21 promoter construct was a kind gift 
provided by Dr. Lieberman (Yin et al., 2004), which consisted of a 2,337-bp fragment of 
the human p21 promoter (El-Deiry et al., 1995), containing two p53-binding consensus 
sites, and with HindIII and XhoI sites added on the ends. It was isolated and inserted into 
the plasmid pGL3-basic (Promega, Madison, WI) to generate construct pGL3-p21-Luci 
plasmid. This pGL3-p21- Luci plasmid was transformed into E. coli DH5Q competent 
cells (Invitrogen) by standard protocol for mass production. The plasmid was prepared by 
using Wizard PureFection Plasmid DNA purification system from Promega. 
 
Transient Transfection and Luciferase Assay -- Hep G2 cells were transfected by 
using Tfx-20 reagent according to the protocol provided by the manufacturer (Promega). 
Hep G2 cells, in DMEM with 10% FBS without antibiotics, were seeded at a density of 2 
× 10  cells/well in 24-well plates and cultured for 4 days in DMEM containing 10% 5
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Chelexed FBS plus 0, 0.4, 4.0, 16.0, or 32.0 µM zinc. Just before transfection, the 
medium was removed. Transfections were performed in triplicate with 500 ng of the 
plasmid DNA containing the wild-type p21 promoter luciferase reporter construct and 10 
ng of an internal control plasmid, pRL-SV40 (Promega). One hour after transfection, the 
transfection medium was changed to the respective medium and cultured for 2 more days. 
Luciferase activity was measured in the Luminometer TD-20/20 (Turner Designs, 
Sunnyvale, CA) by using the Dual-Luciferase reporter Kit according to recommendations 
by the manufacturer (Promega). Changes in firefly luciferase activity was calculated and 
plotted after normalization with changes in renilla luciferase activity in the same sample. 
 
p21 Promoter Accessibility -- The Chromatin Immunoprecipitation (ChIP) Assay of 
Lagger et al. (Lagger et al., 2003), was performed using the ChIP Assay Kit (Upstate 
Biotechnology) according to the manufacturer’s recommended protocol for the 
determination of the association of acetylated histone with the proximal and distal region 
of the p21 promoter. This approach was used to verify our contention that the depression 
of the p21 transcription process by zinc deficiency is partially due to a depressed p21 
promoter accessibility of the proximal and distal (with p53 responsive element) regions 
of the p21 promoter (Fig. 5A). Formaldehyde-crosslinked chromatin was prepared from 
Hep G2 cells and immunoprecipitations was performed using the ChIP Assay Kit. One 
tenth of the DNA from each immunoprecipitation was used in each PCR reaction. All 
PCRs were performed on a Perkin Elmer GeneAmp PCR System 2400 with Applied 
Biosystems’ Golden Taq polymerase. PCR primers were the same as those published by 
other researchers (Lagger et al., 2003), which amplified the proximal (5'-GGT GTC TAG 
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GTG CTC CAG GT-3' and 5'-GCA CTC TCC AGG AGG ACA CA-3') and distal (5'-
GGT CTG CTA CTG TGT CCT CC-3' and 5'-CAT CTG AAC AGA AAT CCC AC-3') 
regions of p21 promoter. Primers for GAPDH promoter (5T-AAA AGC GGG GAG 
AAA GTA GG-3T; 5T-CTA GCC TCC CGG GTT TCT CT-3’) were used as control. 
PCR condition: 95 C for 5 min, once; 95 C for 1min, 50°C for 1min, 72°C for 2 min, 　 　
35 cycles; and 72°C for 7 min, once. The amplified DNA was separated on 2.0 % agarose 
gel and visualized with ethidium bromide. The optical densities of the DNA bands were 
quantified by scanning densitometry (Alpha Innotech) and normalized to that of ZN cells. 
 
 Transient Tansfection of p21 Overexpression Plasmid PCMV-p21 -- HepG2 
cells were cultured in media with respective zinc concentration (ZD = <0.1 µM; ZN = 4 
µM) for 4 days. Thereafter, cells were transiently transfected in serum free DMEM media 
by using Tfx-20 with graded amounts of PCMV-p21 plasmids (1, 3, 5, 7 and 10 μg). 
PCMV plasmid without carrying p21 gene (PCMV-control) was used as control. ZD and 
ZN cells transfected with PCMV-control are indicated as ZD+0 and ZN+0. The PCMV-
p21 plasmid was a kind gift provided by Dr. Ariga (Ono et al., 2000), which consisted of 
a constitutive promoter followed by the full length p21 coding sequence. Both PCMV-
p21 and PCMV320 control plasmids were individually transformed into E. coli DH5α 
competent cells (Invitrogen) by standard protocol for mass production. The plasmids 
were prepared by using Wizard PureFection Plasmid DNA purification system from 
Promega. After transfection, cells were cultured in corresponding media for 2 more days. 
Total proteins were then extracted and subjected to protein expression analysis by 
western-blot. 
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Cdk4 Immunoprecipitation Kinase Assay – Cdk4 binds with cyclin D1 to form an 
active complex that can phosphorylate Rb protein at Ser795 (Pietenpol and Stewart 2002; 
Xiong et al., 1993). The established method of Ding et al. (Ding et al., 2005) that 
measures the phosphorylation of Rb at Ser795 was used. Cells were lysed by using RIPA 
lysis buffer according to manufacturer protocol (Santa Cruz). Total cell lysate was 
immunoprecipitated overnight at 4 oC with: mAb anti-cdk4, mAb anti-cyclin D1, or 
mouse IgG. Immunoprecipitates were then washed twice with the Rb kinase buffer [50 
mM Hepes (pH 7.5), 1 mM EGTA, 10 mM KCl, 10 mM MgCl2, and 1 mM dithiothreitol), 
resuspended in the Rb kinase buffer with the addition of 10 mM ATP and 0.5 μg of 
recombinant Rb protein (QED Bioscience, Inc., San Diego), and incubated with gentle 
shaking for 30 min at 30oC. The kinase assay was stopped by the addition of SDS sample 
buffer. The reactants were subjected to 12% SDS-PAGE, immunoblotted with rabbit anti-
phosphospecific Rb [pSer795] IgG, stripped, and reprobed with rabbit anti-Rb IgG. 
 
 Cell cycle analysis -- DNA contents of cells were assayed by fluorescence-
activated cell sorting (FACS) by using a FACScalibur cytometer (Becton Dickinson, San 
Jose, CA). HepG2 cells were cultured in respective zinc media for one passage, 
trypsinized, washed in PBS (Ca2+, Mg2+ free), and fixed in 70% ethanol. Cells were then 
stained with propidium iodide. Flow cytometry and FACS analysis (FACScanner; Becton 
Dickson) were used to quantify the distribution of DNA fluorescence and intensity. Flow 
cytometric data files were collected and analyzed by using the CELLQuest program 
(Becton Dickinson). A total of 10,000 cell events were collected for DNA analyses. Cell 
cycle distribution percentages of stained nuclei were calculated by using Modfit LT 
software (Verity Software House, Topsham, ME). The calibration standard LinearFlow 
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green and the DNA QC Particle kit, for verification of instrument performance, were 
purchased from Molecular Probes (Eugene, OR) and Becton Dickinson, respectively. 
 
Statistical Analysis -- The data were analyzed with one-way ANOVA by using SPSS 
14.0 Windows software (SPSS Inc., Chicago, IL). The means were further analyzed by 




Zinc-deficient medium depletes cellular zinc. 
HepG2 cells were cultured for one passage in the zinc depleted and supplemented 
media. Growth as measured by cell number was significantly depressed in ZD and ZD0.4 
cells to 63 % and 65% of ZN cells (Fig. 4A). In addition, no differences in cell number 
were observed among the ZN, ZA, ZS and ZD+32 μM cells. Cell viability was very high, 
at the optimal level, and no difference was detected among all treatments (98% and 99% 
or higher as determined by the NucleoCounter method and the Trypan Blue Exclusion 
assay, respectively). Cellular zinc levels were expressed per million cells to correct for 
any differences in cell numbers between plates. In ZD and ZD0.4 cells, cellular zinc 
concentration was reduced to 43 % and 50 %, respectively, of ZN controls (Fig. 4B). 
Moreover, cellular zinc levels in ZA, ZS and ZD+32 μM cells were 52%, 77 % and 85 %, 
respectively, higher than ZN cells. Furthermore, cellular zinc levels in ZS and ZD+32 μM 
cells were higher than ZA. Thus, the supplementation of ZD cells with ZS medium 
(ZD+32 μM), for the last 2 days of culture, was found to normalize cell growth and 
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cellular zinc level to that of the ZN cells. This rescue approach demonstrated the 
specificity of zinc treatment and the speed of normalization of cell growth and cellular 
zinc level by zinc replenishment. 
Zinc depletion decreases nuclear and cytoplasmic p21 protein as well p21 mRNA 
levels. 
Nuclear p21 protein levels in the ZD and ZD0.4 cells were significantly reduced 
to 40 % and 43%, respectively, of ZN cells (Fig. 5A). Cytoplasmic p21 protein levels in 
ZD and ZD0.4 cells were similarly reduced (Fig. 5B). The p21 mRNA levels in ZD and 
ZD0.4 cells were almost 30 % lower than in ZN cells (Fig. 6). In contrast, no significant 
differences were detected in nuclear and cytoplasmic p21 protein levels as well as p21 
mRNA abundance among the ZN, ZA, ZS, and ZD+32 μM cells. Most importantly, the 
rescue approach demonstrated the specificity of zinc treatment and the rapid 
normalization of both p21 protein and mRNA levels by zinc replenishment.  
 
p21 promoter activity is decreased in zinc depleted HepG2 cells. 
Transient transfection of a p21-promoter-luciferase reporter gene into HepG2 
cells indicated that the p21 promoter activity of ZD and ZD0.4 cells was significantly 
reduced to 64% and 66% of ZN cells, respectively (Fig. 7). In contrast, no differences 
were observed among the ZA, ZS, ZD+32 μM, and ZN cells. Thus, the supplementation 
of ZD cells with ZS medium (ZD+32 μM), for the last 2 days of culture, was found to 
normalize the p21 promoter activity to that of the ZN cells. This rescue approach 
demonstrated the specificity of zinc treatment and the speed of normalization of p21 
promoter activity by zinc replenishment. 
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Zinc depletion reduces the p21 promoter accessibility  
To test whether cellular zinc status affects local histone acetylation pattern on the 
p21 promoter, we performed ChIP experiments with chromatin isolated from HepG2 
cells. After cross-linking with formaldehyde, chromatin was sonicated and 
immunoprecipitated with antibodies against the acetylated form of histone H4. In 
addition, ChIP assays were performed in parallel without antibodies to control the 
specificity of the reaction. Moreover, primers specific for the human GAPDH gene were 
used as control. Furthermore, PCRs were performed with standards consisting of fixed 
amounts of genomic DNA as template to assure that amplification reactions were within 
the linear range. As shown in Fig. 8, the amounts of acetylated histone H4 associated 
with the proximal and distal p21 promoter regions were significantly decreased in ZD (73 
± 5%; 64 ± 5%, respectively) and ZD0.4 (82 ± 1%; 77 ± 6%, respectively) cells than in 
ZN (100 ± 3%; 100 ± 3%, respectively) cells. Although there appeared to be a trend for 
the amounts of acetylated histone H4 associated with the proximal or distal p21 promoter 
regions to be lower in ZD than ZD0.4 cells, the differences were not significant. No 
significant changes in acetylation at the GAPDH locus were observed among the 
treatments. In the absence of specific antibodies, no specific PCR products were 
amplified. Our data demonstrate that, in zinc-deficient HepG2 cells, the reductions in p21 
protein and mRNA expression correlate well with the depressed p21 promoter activity 
and accessibility. 
 
Transfection of the PCMV-p21 plasmid, at 5 >g/plate, normalizes p21 protein level 
in ZD cells to that of ZN cells 
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The method of Ariga et. al., (Ono et al., 2000) to overexpress p21, by transient 
transfection of the PCMV-p21 plasmid, was used to normalize the decrease in p21 
protein level induced by zinc deficiency. By transfecting graded amounts of PCMV-p21 
plasmid (1, 3, 5, 7, 10 microgram per plate), which constitutively expressed p21, the 
amount of PCMV-p21 at 5 μg per transfection was established to be the right dosage 
capable of restoring the p21 expression level in the PCMV-p21 transfected ZD cells 427 
(ZD+5) back to the level of ZN control cells (ZN+0) (Fig 6). In addition, ZN cells 
transfected with 5 μg of PCMV-p21 (ZN+5) demonstrated a 48% increase in p21 protein 
level than ZN control cells (ZN+0). 
 
Normalization of p21 protein level in ZD-PCMV-p21 cells restores the cyclin D1- 
cdk4 complex activity to the level of ZN cells. 
The role of p21 as an assembly factor for the formation of active cyclin D1-cdk4 
complex, which modulate cell cycle positively, has been reported in several cell models 
(Kavurma and Khachigian 2003; Kavurma and Khachigian 2004; Noseda et al., 2004). 
Thus, studies were designed to examine whether the repressed p21 is responsible for the 
reduction in cell growth observed in zinc-deficient HepG2 cells. Firstly, the cyclin D1-
cdk4 complex activity was determined by the standard non radioactive method of Ding et. 
al. (Ding et al., 2005). The experimental design involved the usage of ZN and ZD cells 
transfected with PCMV-p21 or PCMV-control plasmids. As a measure of cyclin D1-cdk4 
complex activity, the level of phosphorylation at Ser795 of a recombinant truncated Rb 
protein (Pietenpol and Stewart 2002, Swanton 2004) was determined and was found to be 
significantly lower by only 20% in ZD than ZN cells (Fig. 10). Most interestingly, after 
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the transfection of 5µg PCMV-p21, the cyclin D1-cdk4 complex activity was normalized 
in ZD cells and remained not altered in ZN cells as compared to ZN cells transfected with 
control plasmid (Fig 10). In addition, as a control to assess the quality of the lysate, 
equivalent amount of the lysate from both ZD and ZN cells transfected with PCMV-p21 
or PCMV-control plasmids were electrophoresed by SDS-PAGE and immunoblotted 
with mAb anti-GAPDH (Fig. 10C) and was found to be optimal among all treatments. 
Thus, the results indicated that the small reduction in cyclin D1-cdk4 complex activity 
appeared to be the result of the decreased p21 protein level in ZD cells. 
 
Inhibition of cell growth and G1/S cell cycle progression in zinc-deficient HepG2 
cells are independent of the decrease in p21 protein level. 
Cell growth and cell cycle progression analysis were also determined in the same 
batch of cells used for the measurement of cyclin D1-cdk4 complex activity after the 
rescue of p21 level in ZD cells. The result indicated that cell growth remained repressed 
in ZD PCMV-p21 cells, with normalized p21 expression, as compared to ZD-PCMV-
control cells. (Fig. 11). Most importantly, in the ZN-PCMV-p21 cells, transfected with 
the same amount of PCMV-p21 plasmid, the marked increase in p21 expression was 
accompanied by a 30% reduction in cell growth, which demonstrated the growth 
inhibitory effect of p21 expression at high level. In addition, consistent with our previous 
report (Cui et al., 2002), cell cycle progression was impaired at the G1/S phase in ZD 
cells (Fig. 12). However, the impaired G1/S cell cycle progression remained unchanged 
in the ZD-PCMV-p21 cells, with normalized p21 level and cyclin D1-cdk4 complex 
activity (Fig. 12). Moreover, the G1/S progression was mildly impaired in the ZN-
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PCMV-p21 cells, with markedly elevated p21 protein level, which indicated that the 
overexpressed p21 is functionally effective in inhibiting cell cycle progression and 
growth. Thus, these findings suggest that, in zinc-deficient HepG2 cells, the decreased 





































Figure 4.  Zinc-deficient medium depletes cellular zinc. 
Fig. 4A: HepG2 cells were cultured for one passage in a basal medium depleted of zinc to 
induce severe zinc-deficient (ZD) cells or in the basal medium supplemented with 0.4, 4.0, 
16, or 32 CM zinc to represent mild zinc deficiency (ZD0.4), the amount of zinc in most 
normal media (ZN), the normal human plasma zinc level (zinc-adequate, ZA), or the high 
end of plasma zinc attainable by oral supplementation (ZS), respectively. For the rescue 
treatment, cells were cultured in ZD medium for 4 days and then switched over to ZS 
medium for the last 2 days of culture prior to being harvested as ZD+32μM cells. Cells 
were counted by using hemacytometer. Cell number was expressed as a percentage of ZN 
controls. Values are means ± SEM from 3 experiments. Different letters indicate
significantly different means, P < 0.05. Data were analyzed by one-way ANOVA.
Different letters indicate significantly different means (P < 0.05); while means with the
same letter indicates no significant difference. 
Fig. 4B: Cellular zinc was measured by atomic absorption spectrophotometry. Cellular
zinc levels were expressed as a percentage of ZN controls. Values are means ± SEM from
3 experiments. Different letters indicate significantly different means, P < 0.05. 
 53
















Figure 5.  Low intracellular zinc status reduces p21 protein level. 
Nuclear and cytoplasmic proteins (40 μg) prepared from Hep G2 cells were 
separated on SDS-PAGE, Western blotted, and probed with antibody against p21 
(C-19). The nuclear or cytoplasmic protein blots were also probed with antibody 
against Oct-1 (H-65) or actin (I-19), respectively. The optical densities of the protein 
ba 749 nds were quantified by the Alpha Innotech Imaging System (San Leandro, 
CA). The nuclear (Figure 5A) or cytoplasmic (Figure 5B) p21 protein band was 
normalized to the corresponding Oct-1 or actin value, respectively, and expressed as 
a percentage of ZN cells. Values shown in bar graphs represent means ± SEM from 
3 separate experiments. Data were analyzed by one way ANOVA. Different letters 
indicate significantly different means (P < 0.05); while means with the same letter 













Figure 6. Low intracellular zinc status reduces p21 mRNA level.  
Total RNA was isolated from cells by using RNeasy kit (Qiagen, Valencia, CA). 
The abundance of p21 mRNA was measured by using a nonradioactive RPA kit 
(BD Biosciences, San Diego, CA) according to the manufacturer’s instructions. 
The RPA probe set, which included p21 and GAPDH probe, was from the same 
manufacturer. The optical densities of the protected p21 bands were quantified by 
the Alpha Innotech imaging system (San Leandro, CA) and then normalized to that 
of GAPDH. Values shown in bar graphs represent means ± SEM from 3 separate 
experiments. Data were analyzed by one-way ANOVA. Different letters indicate 
significantly different means (P < 0.05); while means with the same letter 




































Figure 7. Low intracellular zinc status depresses p21 promoter activity. 
HepG2 cells were cultured in media with respective zinc concentration (ZD = <0.1 μM;
ZD 0.4 = 0.4 μM; ZN = 4 μM; ZA = 16 μM; and ZS = 32 μM zinc supplemented to the
basal medium) for 4 days. Thereafter, cells were transiently transfected in serum free
DMEM media by using Tfx-20 with 500 ng of luciferase reporter construct (PGL3-p21)
containing the p21 promoter, together with 10 ng pRL-SV40 as internal control. PGL3
basal vector without carrying any promoter was used as the vector control. After
transfection, cells were cultured in corresponding media for 2 more days. For the rescue
treatment, cells were cultured in ZD medium for 4 days, transfected and then switched
over to ZS medium for the last 2 days of culture prior to being harvested as ZD+32μM
cells. Cells extracts were then assayed by Dual-Luciferase reporter system and signals
were measured by a Luminometer. Values represent means ± SE from 3 experiments.
Data were analyzed by one-way ANOVA. Different letters indicate significantly different













 Figure 8. Acetylation of histones on the proximal and distal p21 promoter is 
 depressed in zinc-deficient HepG2 cells. 
 (A) Relative positions of PCR primers for the amplification of proximal or distal p21
promoter fragments are shown in a schematic drawing. (B) Chromatin
immunoprecipitation (ChIP) analysis of the p21 proximal promoter was performed 
with antibodies to acetylated histone H4 and unspecific antibodies (control) by using
chromatin isolated from HepG2 cells. (C) Same as for panel B, but with ChIP 
analysis for the p21 distal promoter. (D) Primers for the human GAPDH gene were 
used as a control. The data shown are representative of three independent 


































Figure 9. Transfection of p21 expression plasmid PCMV-p21, at 5 μg/plate, restores
the p21 protein level in ZD cells back to that of ZN cells. 
HepG2 cells were cultured in media with respective zinc concentration (ZD = <0.1 μM;
ZN = 4 μM) for 4 days. Thereafter, cells were transiently transfected in serum free
DMEM media by using Tfx-20 with graded amounts of PCMV-p21 plasmids (1, 3, 5, 7
and 10 μg). PCMV plasmid without carrying p21 gene was used as control (PCMV801
control). ZD or ZN cells transfected with PCMV-control plasmid are indicated as ZD+0 or 
ZN+0 cells, respectively. After transfection, cells were cultured in corresponding media 
for 2 more days. Total proteins were then extracted and subjected to protein expression 
analysis by western-blot. Values are means ± SEM from 3 experiments. Different letters 
indicate significantly different means, P < 0.05. Data were analyzed by one-way ANOVA. 

























Figure 10. Transfection of p21 expression plasmid PCMV-p21, at 5 μg/plate, restores
the cyclin D1-cdk4 complex activity in ZD cells back to that of ZN cells. Equivalent 
amount of lysate (900 μg) was immunoprecipitated (IP) with mAb anti-cdk4 or mouse 
IgG, washed, the immunoprecipitated protein subjected to the cdk4 kinase assay, followed 
by 12% SDS-PAGE and immunoblotting with anti-Rb [pSer795] IgG (A), stripped, and 
reprobed with anti-total Rb IgG (B). C, an equivalent amount of lysate (100 Cg) was 
subjected to SDS-PAGE and immunoblotted with mAb anti-glyceraldehyde-3-phosphate 
dehydrogenase (G3PDH) as a control for the quality 816 of the lysate. Values are means ± 
SEM from 3 experiments. Different letters indicate significantly different means, P < 0.05. 
Data were analyzed by one-way ANOVA. Different letters indicate significantly different 





















Figure 11. Zinc deficiency induced inhibition of cell growth remains unchanged 
after normalization of p21 protein level. 
HepG2 cells were cultured in media with respective zinc concentration (ZD = <0.1 μM;
ZN = 4 μM) for 4 days. Thereafter, cells were transiently transfected in serum free
DMEM media by using Tfx-20 with either 5 μg PCMV-p21 or control plasmid per 100 
mm plate. After transfection, the cells were cultured in corresponding media for 2 more 
days. Cell numbers were counted and expressed as % of ZN control. Values are means ± 
SEM from 3 experiments. Different letters indicate significantly different means, P < 0.05. 
Data were analyzed by one-way ANOVA. Different letters indicate significantly different




























Figure 12. Zinc deficiency induced inhibition of G1/S cell cycle progression 
remains unchanged after normalization of p21 protein level. 
In cell cycle analyses, DNA content of Hep G2 cells was assayed by flow cytometry
using a FACScalibur cytometer. Cells were cultured in respective zinc concentration 
(ZD = <0.1 μM; ZN = 4 μM) for 4 days. Thereafter, cells were transiently transfected in
serum free DMEM media by using Tfx-20 with either 5 μg PCMV-p21 or control
plasmid. After transfection, cells were cultured in corresponding media for 2 more days.
Washed cells were fixed in ethanol and stained for DNA content. Flow cytometric data
files were collected and analyzed using the CELLQuest program. A total of 10,000 cell
events were collected for DNA analyses. Cell cycle distribution percentages of stained
nuclei were calculated using Modfit LT software. The calibration standard LinearFlow
green and the DNA QC particle kit were used for verification of instrument 





In previous studies (Cui et al., 2002), we have reported reductions in cell growth 
and cellular zinc status in zinc-deficient HepG2 cells. In addition, cellular zinc status was 
highly responsive to the zinc content of the culture medium among treatments. Moreover, 
cell cycle analysis indicated that progression from G1 to S phase was depressed in ZD 
cells. Furthermore, no DNA fragments, were detected in the region M1 of flow 
cytometric examinations for all treatments, which indicate the presence of very little or 
no apoptotic cells. In view of available data indicating that p21 repression and 
overexpression may lead to depressed cell cycle progression, we have designed the 
present study to examine the influence of zinc status on the transcriptional process of the 
p21 gene. In the present study, similar reductions in cell growth for ZD cells and cellular 
zinc status among zinc deficient cells were observed as in our previous studies. Thus, the 
changes in cell growth in ZD cells and cellular zinc status among treatments were 
similarly replicated in the present studies. 
 
In the present report, we have presented multiple lines of evidence for the first 
time that the transcriptional process and expression of p21 are depressed in zinc-depleted 
HepG2 cell. The observed reductions of 60% in nuclear p21 protein and almost 30% in 
p21 mRNA in zinc-depleted cells as compare to control ZN cells suggest that the 
transcriptional process might be compromised in zinc-depleted cells. In view of a similar 
magnitude of reduction for cytoplasmic p21 protein was also observed in zinc depleted 
cells, the observed reduction in nuclear p21 protein appears unlikely to have resulted 
from a decreased transport into the nucleus or an enhanced turnover in the nucleus. To 
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explain for the larger magnitude of reduction in protein level than mRNA abundance in 
zinc-deficient cells, an impaired translational process or enhanced degradation of p21 
protein or both may possibly have contributed to the higher magnitude of reduction in 
p21 protein level in zinc-deficient HepG2 cells. Nevertheless, in the present study we 
have elected to concentrate our efforts on the transcriptional process by determining the 
influence of zinc status on the p21 promoter activity and accessibility. In the present 
study, the p21 promoter activity was measured by transient transfection of a p21 
promoter-reporter gene into HepG2 cells. Marked reductions of 36% and 34% in p21 
promoter activity in ZD and ZD0.4 cells, respectively, as compared to ZN cells indicate 
that the transcription process was compromised by zinc deficiency. In addition, the 
supplementation of ZD cells with ZS medium, for the last day of culture, was able to 
normalize the p21 promoter activity to that of ZN cells. This approach substantiates the 
specificity of zinc supplementation and the speed for normalization of p21 promoter 
activity by zinc replenishment. Moreover, the similar magnitude of reduction for p21 
mRNA level to almost 30% lower in zinc-deficient cells than controls as compared to the 
34 to 36% reduction for p21 promoter activity, may suggest that the depressed promoter 
activity is mainly responsible for the reduced mRNA abundance. 
 
DNA exists in the form of highly organized chromatin in the eukaryotic nucleus. 
The nucleosome is the basic unit with DNA wrapped around an octamer of histones, 
comprising of a pair of H2A, H2B, H3, and H4. To activate gene transcription, the highly 
dense chromatin structure must be disrupted by chromatin remodeling complexes to 
enhance the accessibility of the promoter of a gene to transcription factors. Histone 
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modifying enzymes and ATP-dependent remodeling complexes are two major groups of 
chromatin modifying complexes capable of disrupting chromatin structure. Among the 
well-characterized histone modifying enzymes, histone acetytransferase is one that 
acetylates the histone tails, reduces the interaction between DNA and histone, enhances 
the accessibility of DNA to transcriptional factors, and promotes transcriptional 
activation (Smirnova 2000). The chromatin immunoprecipitation (ChIP) assay, which 
employs antibodies against epigenetic protein markers such as acetylated histones, has 
been used to determine the chromatin state of individual genes.  
 
Recent ChIP experiments performed by Lagger et al. (Lagger et al., 2003) 
demonstrated that, upon induction by actinomycin D, p53 can replace HDAC at the p21 
promoter, and the resultant increase in histone acetylation on the p21 promoter correlates 
well with the activation of the p21 gene. Similar ChIP studies by Liu et al. (Liu et al., 
2003) reported that the amount of acetylated histones on the p21 promoter, especially the 
proximal promoter, directly correlate with the extent of p21 expression.  
 
In our ChIP study, we have selected a region proximal to the TATA box as the 
proximal p21 promoter region. The proximal promoter is the region to which the basal 
transcription machinery would bind. In addition, we have selected a region containing the 
first downstream p53 responsive element as the distal p21 promoter region. Both 
promoter regions are the same as those used by Lagger et al. (Lagger et al., 2003) and are 
similar to those used by Liu et al. (Liu et al., 2003). Data from our ChIP experiments 
indicate that in ZD and ZD0.4 cells, the amounts of acetylated histone H4 on the 
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proximal region of the p21 promoter were decreased to 73% and 82% of ZN cells, 
respectively. Similarly, the amounts of acetylated histone H4 on the distal region of the 
p21 promoter were markedly reduced in ZD and ZD0.4 cells to 64 % and 77% of ZN 
cells, respectively. These reductions in acetylated histone H4 on the proximal and distal 
regions of the p21 promoter suggest that the p21 promoter in zinc-depleted cells may be 
less accessible to the transcription machinery. Thus, the present ChIP data provide 
another line of evidence, which supports the promoter activity data, indicating that the 
transcriptional process is depressed in zinc depleted cells. Furthermore, the magnitude of 
reductions in histone acetylation on the p21 promoter correlates well the magnitude of 
depressed p21 promoter activity and p21 mRNA abundance in zinc depleted cells.  
 
p21 has been commonly reported as a negative cell cycle regulator by acting as an 
inhibitor of cyclin/cdk. In this context, a repression of p21 enhances cell cycle 
progression. However, p21 may also function as positive cell cycle regulator by 
functioning as an assembly factor for cyclin D1-cdk4 complex (LaBaer et al., 1997). In 
this context, repression of p21 impairs cell cycle progression. Recently, impairment of 
cell proliferation induced by a repressed p21 expression has been demonstrated in several 
cell models including smooth muscle cells (Kavurma and Khachigian 2003; Kavurma 
and Khachigian 2004), endothelial cells (Noseda et al., 2004) and LoVo colon cancer 
cells (Arango et al., 2003). Therefore, the ability of the depressed p21 level, induced by 
zinc deficiency, in down-regulating cyclin D1-cdk4 activity, which in turn contributing to 
the cell growth depression was investigated. The result indicated that cyclin D1-cdk 
complex kinase activity was significantly lower by 20% in ZD cells as compared to ZN 
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cells. By restoring the p21 protein level in ZD cells back to the level of ZN cells, with 
transient transfection of PCMV-p21 plasmid that constitutively expressed p21, the cyclin 
D1-cdk4 complex activity in ZD-PCMV-p21 cells was normalized to the same level as in 
ZN cells. Thus, the decrease in p21 protein level in ZD cells appeared to be responsible 
for the small reduction in cyclin D1-cdk4 complex activity. However, data from both cell 
growth and cell cycle analysis indicated that impaired cell growth and G1/S cell cycle 
progression remained unaltered in ZD-PCMV-p21 cells, with restored p21 protein level 
and cyclin D-cdk4 complex activity. Thus, in zinc-deficient HepG2 cells, the decrease in 
p21 level appeared not to be responsible for the inhibition of cell growth and G1/S 
progression. Therefore, in zinc-deficient HepG2 cells, other p21 unrelated effects of zinc 
deficiency may be responsible for the inhibition of cell cycle progression and growth. 
Recently, MacDonald (MacDonald 2000) reviewed past reports on the role of zinc in 
growth and cell proliferation. However, the exact mechanism responsible for the 
inhibition of cell growth induced by zinc deficiency has not been fully established. The 
author postulated that metalloenzymes (Chesters and Boyne 1991; Wu and Wu 1987) 
such as DNA polymerase, involved in DNA synthesis, may be responsible for the 
reduction in DNA synthesis and cell growth. 
 
In summary, the present data suggest that the reduction in acetylated histone 4 on 
the p21 promoter resulted in a depressed p21 promoter accessibility, which contributed to 
the decrease in p21 promoter activity and the down-regulation of p21 mRNA and protein 
expression in zinc-depleted HepG2 cells. Moreover, the decreased level of p21 protein 
appeared not to be responsible for the impaired cell growth and G1/S cell cycle 
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progression in zinc-depleted HepG2 cells. Recent studies in our laboratory (Alshatwi et 
al., 2006) have established in zinc-deficient HepG2 cells a marked reduction in the level 
of nuclear p300 protein, which is known to be the main coactivator recruited by p53 to 
responsive elements of a target gene. Apart from the scaffolding role of p300, its function 
in chromatin remodeling has been identified through the intrinsic histone 
acetyltransferase (HAT) activity of p300 (Kalkhoven 2004). Thus, the marked reduction 
in nuclear p300, accompanied by an expected reduction in its intrinsic HAT activity, may 
have contributed to the observed decrease amounts of acetylated histone H4 associated 
with the proximal and distal promoter regions of the p21 gene in the zinc-deficient cells. 
Our future studies will be designed to establish the influence of cellular zinc status on the 








The involvement of p53 and p21 signal pathway in the G2/M cell cycle 
progression of zinc supplemented normal human bronchial epithelial (NHBE) cells was 
examined using the siRNA approach. Cells were cultured for one passage in different 
concentration of zinc: <0.4 μM (ZD) as zinc-deficient; 4 μM as normal zinc level in 
culture medium; 16 μM (ZA) as normal human plasma zinc level; and 32 μM (ZS) as the 
high end of plasma zinc attainable by oral supplementation. The nuclear p21 protein level 
and mRNA abundance as well as promoter activity in ZS cells, but not in ZD cells, were 
markedly elevated to almost 2-fold when compared to ZN control cells. G2/M blockage 
in ZS cells was coupled with the observation of elevated p21 gene expression. The 
positive linkage of p21 elevation and G2/M blockage in ZS cells was demonstrated by 
gene knock-down approach. In ZS cells, the abrogation of p21 protein induction by the 
transfection of p21 siRNA was shown to alleviate the G2/M blockage. Because p53 
protein level was also found to be elevated to a magnitude similar to that of p21 protein 
in ZS cells, a similar gene knock-down approach was used to establish if the p21 
upregulation in ZS cells was p53 dependent. Abolishment of the increase in p53 protein 
in ZS cells with transfection of p53 siRNA treatment normalized the elevated p21 protein 
to a similar level as in ZN control cells, which demonstrated that the p21 induction is 
p53-dependent. Furthermore, the normalization of p53 protein by siRNA in ZS cells 
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alleviated cell growth depression and G2/M blockage, which demonstrated that p53 was 
involved in the high zinc status induced G2/M blockage and growth depression. Thus, 
high zinc status in NHBE cells upregulates p53 expression which in turn elevates p21 that 
eventually induces G2/M blockage. 
 
Introduction 
The accuracy of genomic DNA replication is ensured by two major checkpoint 
controls at G1-S and G2/M transition during cell division. Therefore, deregulation of 
these checkpoint controls would cause genomic instability, which has been implicated in 
carcinogenesis (Elledge et al., 1996). The tumor suppressor gene, p53, has been found to 
be mutated in a large fraction of human cancers and is a major gatekeeper of cell cycle 
division (Levine et al., 1997). p53 protects mammals from carcinogenesis by inducing 
apoptosis, DNA repair and cell cycle arrest in response to a variety of stresses (Ko and 
Prives 1996; Levine, 1997; Agarwal et al., 1998). In response to ionizing or UV radiation 
or other chemical stresses, p53 has been found to mediate cell cycle arrest mainly at G1-S 
transition through the immediate downstream target, p21/waf1 (El-Deiry et al., 1993; 
Harper et al., 1993; Xiong et al., 1993). However, circumstantial evidences have emerged 
to support that p53 is also involved in the regulation of G2/M transition through the 
modulation of p21 expression. 
 
Involvement of p53 in G2/M transition in response to DNA damage stress has 
been elucidated by two major approaches. The first approach was to investigate the effect 
of eliminating p53 on the G2/M checkpoint. When p53 protein was inactivated by the 
human papilloma virus E6 protein (HPV-E6), the number of IMR-90 normal fibroblasts 
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entering mitosis after exposure to ionizing radiation was much higher, suggesting that 
p53 is required for G2 arrest (Thompson et al., 1997). In another case, expression of a 
truncated form of p53 that formed inactive tetramers with endogenous wild type p53 
shortened the G2 delay in IMR-90 fibroblasts (Thompson et al., 1997). Overexpression of 
SV40 large T antigen in IMR-90 fibroblasts shortened the G2 delay stimulated by 
exposure to ionizing radiation, which was explained by inactivation of p53 protein bound 
by large T antigen (Chang et al., 1997). The p53 null cell line, human colorectal tumor 
cell line HCT116, more clearly revealed the role of p53 played in the G2 checkpoint 
(Bunz et al., 1998). After exposure of HCT116 to ionizing radiation, although the cells 
initially arrested at G2/M, the arrest was not stable and cells eventually entered mitosis. 
This indicates that p53 is not required for the initial arrest of HCT116 cells in G2 but is 
essential for the long-term maintenance of the arrest. The second approach was to 
examine the effect of overexpressing p53 on the G2/M transition.  Agarwal et al. (1995) 
have used a tetracycline-inducible system in p53-null human fibroblasts to demonstrate 
the role of p53 in G2 arrest. They firstly synchronized all p53-null human fibroblasts 
population to the beginning of S phase with mimosine. Thereafter, minosine was 
removed and p53 was induced with tetracycline. They found that up to 60% of cells 
became arrested at G2/M and the level of phosphorylated histone H1b, which is normally 
highest during mitosis, was very low in these arrested cells (Agarwal et al., 1995; Taylor 
et al., 1999). These results indicate that p53 is involved in G2 arrest and that the arrest is 
not due to an aborted attempt at mitosis, followed by arrest in G1. 
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 Successful G2/M transition is governed by cyclin dependent kinase Cdc2 (Nurse 
1990). Cdc2 binds to Cyclin B to form a complex which is activated by Cdc25 at the 
onset of mitosis (Draetta and Eckstein 1997). The mechanism by which p53 regulates the 
G2/M transition is proposed to mediate its immediate downstream transcriptional target, 
p21, which is a Cdc2 inhibitor (Winters et al., 1998). The  involvement of p21 in G2 
checkpoint has been widely documented. Induction of p21 using a tetracycline-regulated 
system caused a number of different cell lines, including human Hela cervical carcinoma 
cells, Saos-2 and U2OS osteosarcoma cells, RKO colorectal carcinoma cells, H1299 lung 
carcinoma cells, and Rat 1 fibroblast cells, to arrest at G2 (Bates et al., 1998; Medema et 
al., 1998; Niculescu et al., 1998). Similar to HCT116 colorectal tumor cells lacking p53, 
the cells lacking p21 also did not arrest stably in G2 after exposure to ionizing radiation 
(Bunz et al., 1998). This failure to arrest was associated with levels of Cdc2 kinase 
activity that is higher than those observed in cells with p21. Additional evidence linking 
p21 to the G2/M transition comes from its restored abundance when the cells enter G2 
(Dulic et al., 1998).  
 
 Metal ions are vital for many biological processes, such as transcription, 
respiration and growth. However, excess accumulation of essential metals such as zinc, 
copper, cadmium, and mercury can be detrimental. Although, zinc is not redox-active 
under physiological concentrations and is less toxic than most metal ions, at high 
concentration, zinc toxicity is associated with reduced iron absorption, impaired immune 
function (Whittaker et al., 1998) and neuronal death (Chen et al., 2003; Koh et al., 1994). 
In our previous study, we found that G2/M arrest coupled with depressed growth were 
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observed in Normal Human Bronchial Epithelial (NHBE) cells cultured in zinc-
supplement media (unpublished data). Signal cascade of Gadd45 and p53 as well as p38 
were found to be associated with this G2/M arrest (unpublished data). To further uncover 
the detailed molecular mechanism, this study was designed to investigate the cyclin 
inhibitor, p21, for its possible role in zinc-supplement induced G2/M arrest in NHBE 
cells. This study has provided evidence to show that in response to the adverse effect of 
zinc supplementation, the enhanced expression of p53 may be triggered to suppress 
G2/M transition through the upregulation of the Cdc2/CyclinB inhibitor, p21. NHBE 
cells have been selected for this study because they are more representative of the cell 
population during lung tissue transformation and are considered to be progenitor cells for 
human bronchial cancer. 
 
Methods and Materials 
Cell culture -- NHBE cells were purchased from Cambrex Bio Science (Walkersville, 
MD). Cells were cultured with bronchial epithelial cells growth medium (BEGM) 
supplemented with 0.5 µg/ml epinephrine, 10 µg/ml transferrin, 5 µg/ml insulin, 0.1 
ng/ml retinoic acid, 52 µg/ml bovine pituitary extract, 0.5 µg/ml hydrocortisone, 0.5 
pg/ml human recombinant epidermal growth factor, and 6.5 ng/ml triiodothyronine (as 
growth supplements) without antibiotics, and incubated at 37°C in a 5% CO2 incubator. 
Endotoxin-free medium was used (<0.005 endotoxin units/ml). Seeding density was 
around 3,500 cells per cm2 of tissue culture dish. The medium was changed every 2 days. 
The cells reaching 80% confluence after culturing for 6 days were counted as one passage. 
The cells were subcultured at a ratio of 1: 8 with trypsin-EDTA after reaching confluency. 
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Cells at passage 3 were used for zinc treatment. Zinc treatments were carried out by 
adding zinc as a form of ZnSO4 to the zinc-free BEGM baseline media to make the zinc-
normal (ZN) medium that contained 4 μM of ZnSO4, the zinc-adequate medium (ZA) 
that contained 16 μM of ZnSO4, and the zinc-supplemented medium (ZS) that contained 
32 μM ZnSO4. The zinc-free basal BEGM medium, which contained trace amount of 
detectable zinc ion (<0.4 μM) as measured by flame atomic absorption 
spectrophotometry, was used as the zinc-depleted medium (ZD).  The ZN medium was 
used as a comparison to standard culture media and was used as the control group for 
experiments.  The ZA treatment was used as a representative of human plasma zinc levels, 
and the ZS group was used to represent plasma zinc levels attainable by oral 
supplementation in humans. After NHBE cells were subcultured into one of the four 
corresponding groups, the cells were cultured overnight in ZN media before changing to 
their respective medium.  Cells were then cultured in ZD, ZN, ZA and ZS for 6 days. The 
cell number was determined by using a hemocytometer, and cell viability was assessed 
by trypan blue dye exclusion. Cell morphology was evaluated by using a phase-contrast 
microscope (Olympus, Tokyo, Japan).  
Cellular zinc and DNA determination – After reaching 80% confluence, cells were 
harvested by trypsinizing with trypsin-EDTA for 5 min in 37oC incubator. Cell 
suspensions were then centrifuged at 500 x g for 5 min at room temperature. Cell pellets 
were washed with phosphate-buffered saline (PBS) buffer, centrifuged again and then 
resuspended into 1.5ml PBS and sonicated for two 30 second intervals. Thereafter, an 
aliquot of the sonicated cell suspension was used to measure cellular zinc content by 
flame atomic absorption spectrophotometry (Hitachi, San Jose, CA). Zinc standard 
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solutions (Fisher, Pittsburgh, PA) ranging from 0.05 ppm to 1.0 ppm were used to 
generate a linear standard curve.  The zinc content of the cells was determined based on 
these zinc reference solutions. In addition, the certified zinc solutions were compared to 
bovine Liver Standard Reference (U.S. Department of Commerce, National Institute of 
Standards, Gaithersburg, MD).  Appropriate blanks were employed for all measurements.  
From the same sample, a small aliquot of the sonicated cell suspension was used to 
measure cellular DNA content using diphenylamine (Williams et al., 1986). Data were 
expressed as cellular zinc per microgram of DNA because of the linear relationship 
between cellular DNA and cell number we previously established (Williams et al., 1986). 
RNase Protection Assay -- Total cellular RNA was isolated from HepG2 cells, using the 
RNeasy Mini Kit (Qiagen, Valencia, CA), according to manufacturer’s instructions. The 
integrity of the RNA was verified by RNA gel electrophoresis. The mRNA abundance of 
p21 was measured by the non-radioactive RNase Protection Assay System (BD 
Biosciences, San Diego, CA), according to manufacturer’s instructions. The human 
GAPDH probe was used as internal reference for normalization. Biotin-labeled 
riboprobes were synthesized using non-Rad In Vitro Transcription kit with T7 RNA 
polymerase (BD Biosciences) according to manufacturer’s instructions. 
Nuclear and Cytoplasmic Extract Preparation -- The NE-PER Nuclear and 
Cytoplasmic Extraction Reagents and the Halt Protease Inhibitor Cocktail Kits (Pierce 
Biotechnology, Rockford, IL) were used for nuclear and cytoplasmic extracts preparation 
according to the manufacturer’s instructions, which are based on the method of Smirnova 
et al. (Smirnova 2000). Nuclear and cytoplasmic extracts were then stored in aliquots at   
-80°C. Protein concentrations were determined by using the BCA Protein Assay Reagent 
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kit (Pierce). Contaminations of nuclear extracts by cytoplasmic proteins or contamination 
of cytoplasmic extracts by nuclear proteins, detected by Western blot analysis of Hsp90 
or Oct-1, respectively, were routinely found to be less than 5% in our lab.  
Western Blot Analysis -- Forty µg of nuclear and cytoplasmic protein were resolved on 
a 10% SDS-polyacrylamide gel electrophoresis and transferred to Hybond ECL 
nitrocellulose membrane (Amersham Pharmacia Biotech, Piscataway, NJ) by using a 
mini-transfer system (Bio-Rad, Hercules, CA).  Membranes were blocked with 5% nonfat 
dry milk in PBS-T (10mM phosphate buffer pH7.3, 137mM NaCl, 2.7mM KCL, and 
0.1% Tween 20) for 1 h at room temperature, prior to incubation with 1 µg/ml of a rabbit 
anti-p21 polyclonal antibiody (C-19) from Santa Cruz Biotechnology (Santa Cruz, CA), 
in PBS-T containing 5% nonfat milk at 4 °C overnight. Membrane was then washed three 
times with PBS-T and blotted with a secondary antibody conjugated with horseradish 
peroxidase (Santa Cruz) at room temperature for 1 h, followed by three washes in PBS-T. 
The protein was visualized by using the Western Blot Luminol Reagent (Santa Cruz 
Biotechnology) and exposed to film. The optical densities of the protein bands were 
quantified by the Alpha Innotech Imaging System (San Leandro, CA). 
p21 Promoter Activity - The influence of zinc status on the human p21 gene promoter 
activity was studied by transient transfection of a p21-promoter-luciferase gene into Hep 
G2 cells. This approach was used to provide further evidence that the transcription 
process is depressed by a reduction in p21 gene promoter activity in                         
zinc-deficient Hep G2 cells.   
Preparation of Luciferase Construct. The p21 promoter construct was a kind gift 
provided by Dr. Lieberman (Yin et al), which consisted of a 2,337-bp fragment of the 
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human p21 promoter (base pairs –2258 to –4594) (El-deiry 1995), containing two p53-
binding consensus sites, and with HindIII and XhoI sites added on the ends. It was 
isolated and inserted into the plasmid pGL3-basic (Promega, Madison, WI) to generate 
construct pGL3-p21-Luci plasmid. The pGL3-p21-Luci plasmid was transfected into E. 
coli DH5α competent cells (Invitrogen) by standard protocol for mass production. The 
plasmid was prepared by using Wizard PureFection Plasmid DNA purification system 
from Promega.  
Transient Transfection and Luciferase Assay - Hep G2 cells were transfected by using 
Tfx-20 reagent according to the protocol provided by the manufacturer (Promega). Hep 
G2 cells, in DMEM with 10% FBS without antibiotics, were seeded at a density of 
2 × 105 cells/well in 24-well plates and cultured for 4 days in DMEM containing 10% 
Chelexed FBS plus 0, 0.4, 4.0, 16.0, or 32.0 µM zinc. Just before transfection, the 
medium was removed. Transfections were performed in triplicate with 500 ng of the 
plasmid DNA containing the wild-type p21 promoter luciferase reporter construct and 
10 ng of an internal control plasmid, pRL-SV40 (Promega). One hour after transfection, 
the transfection medium was changed to their respective media and cultured for 2 more 
days. Luciferase activity was measured in the Luminometer TD-20/20 (Turner Designs, 
Sunnyvale, CA) by using the Dual-Luciferase reporter Kit according to recommendations 
by the manufacturer (Promega). Changes in firefly luciferase activity was calculated and 
plotted after normalization with changes in renilla luciferase activity in the same sample.  
Cell Cycle Analysis -- DNA contents of cells were assayed by fluorescence-activated 
cell sorting (FACS). NHBE cells were cultured in ZD, ZN, ZA, and ZS media for one 
passage, trypsinized, washed in PBS (Ca2+, Mg2+ free), and fixed in 70% cold ethanol. 
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Cells were stored at 4°C. For staining, cells were collected by centrifugation, and pellets 
were suspended in 1.0 ml propidium iodide staining solution (50 mg per ml propidium 
iodide, 100 U per ml RNase in PBS), and incubated at room temperature for 1 h. Staining 
was quantitated with a FACSCalibur cytometer (Becton Dickinson, San Jose, CA). The 
data files were analysed by using the CELLQuestPro software program (Becton 
Dickinson, San Jose, CA). Cell cycle distribution percentages of stained nuclei were 
calculated by using Modfit LT software (Verity Software House, Topsham, ME). The 
calibration standard LinearFlow green and the DNA QC Particle kit, for verification of 
instrument performance, were purchased from Molecular Probes (Eugene, OR) and 
Becton Dickinson, respectively.  
siRNA transfection – siRNA duplex against p21 (sc-29427) and p53 (SC-29435) were 
purchased from Santa Cruz Biotechnology company. A control siRNA specific targeting 
to the Luciferase  DNA sequence was used as a negative control. For cell transfection 
with siRNA, NHBE cells cultured on culture dishes at 60% confluency, and siRNA were 
introduced into the cells using RNAiMAX transfection reagent (Invitrogen, Carlsbad, CA) 
according to the manufacturer’s recommendations. Aliquots of 600pmol of siRNA-p21 
were diluted with Opti-MEM medium (Invitrogen, Carlsbad, CA), and another solution 
containing lipofectamine transfection reagent was also diluted with Opti-MEM medium. 
These two mixtures were combined together at room temperature with gentle vortex and 
incubated for 20 mins followed by an addition of 10 ml corresponding medium for the 
treatment groups. The mixture was then overlaid onto the 60% confluent NHBE cells. 
After 48 hours, cells were harvested for cell cycle and western blot analyses. 
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Statistical Analysis -- Each experiment was repeated at least three times with each 
experiment yielding essentially identical results. Data were expressed as mean ± SEM. 
Statistical comparisons were carried out by one-way analysis of variance (ANOVA). 
Means were examined by the Least Significant Difference post hoc analysis (SPSS Inc., 
Chicago, IL). P < 0.05 was considered statistically significant. 
 
Result 
Zinc supplementation reduces cell growth of Normal Human Bronchial Epithelial 
(NHBE) Cells. 
In vitro content of cellular zinc in ZD cells, as measured by flame atomic 
absorption spectrophotometry, was 70% lower than ZN control cells (Fig. 13A). 
Moreover, cellular zinc levels in ZA and ZS cells were 118% and 435%, respectively, 
higher than ZN cells.  Growth as measured by cell number was significantly depressed in 
ZD, ZA and ZS cells to 85%, 90 % and 70%, respectively, of ZN cells (Fig. 13B).  
 
Zinc supplementation suppresses G2/M progression 
A significant delay in G2/M cell cycle progression was observed in ZS NHBE cells 
(19.8%) when compared to ZN cells (12.9) (Fig.14). The finding confirmed our previous 
report of G2/M blockage in ZS NHBE cells (Shih et al., 2006). The G2/M suppression 
was smaller in magnitude in ZA cells, with 15.9% of cells in G2/M (Fig.14). In contrast, 
no change was observed in ZD cells, with 11.9% cells in G2/M, when compared to ZN 
cells (Fig.14). This result indicates that the impaired G2/M progression in zinc 
supplemented NHBE cells is responsible for depressed cell growth. 
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Zinc supplementation upregulates p21 protein and mRNA levels as well as p21 
promoter activity 
p21 mRNA levels in the ZA and ZS cells were drastically upregulated to almost 
200% of ZN cells (Fig. 15). Consistent with the pattern of p21 mRNA expression, 
nuclear p21 protein levels in ZA and ZS cells were similarly upregulated (Fig. 16). In 
contrast, no significant differences were detected in nuclear p21 protein levels as well as 
p21 mRNA abundance between the ZD and ZN cells (Fig. 15 & 16). Transient 
transfection of a p21-promoter-luciferase reporter gene into NHBE cells indicated that 
the p21 promoter activity of ZS cells was significantly induced to 150% and 200% of ZN 
cells, respectively. In contrast, no difference was observed between ZD and ZN cells (Fig. 
17).  
 
Transfection of the p21 siRNA, at 200 pmole/plate, normalizes the induced p21 
protein level in ZS cells to that of ZN control cells 
By transfecting graded amounts of p21 siRNA (600, 400, and 200 pmole per 
plate), the amount of p21 siRNA at 200 pmole per transfection was able to abrogate the 
elevated  p21 protein level in ZS cells and normalize it to that of ZN control cells (Fig. 
18). In addition, ZN cells transfected with 200 pmole of p21 siRNA showed a near 20% 
decrease in p21 protein level than ZN control cells. The same batch of cells with 
normalized p21 protein level in ZS cells were used for G2/M cell cycle analysis to 
determine if G2/M arrest was altered or not. 
Normalization of p21 protein level in ZS cells with p21 siRNA alleviates the G2/M 
blockage and restores depressed cell growth 
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After knocking down the induced protein level of p21 in ZS cells to a similar 
level as in ZN cells with p21 siRNA, the cells were subjected to cell cycle analysis to 
examine the association of p21 induction with G2/M arrest in ZS cells. As shown in 
Figure 19, the normalization of p21 protein level in ZS cells alleviated the G2/M 
blockage from 20% and normalized it back to 12% which was similar to the % of ZN 
control cells in G2/M phase. As for ZN cells transfected with same amount of p21 siRNA, 
the percentage of cells in G2/M was slightly reduced. The cell growth as measured by 
cell numbers per plate indicated that, in ZS+siP21 cells, the normalization of p21 protein 
level by using p21 siRNA restored the originally depressed growth of ZS cells back  to 
the same level of ZN control cells (Figure 20). 
 
Upregulation of p21 in ZS cells is dependent on p53 expression 
p53 was widely reported as an immediate upstream regulator of p21 for its role 
played in G1/S cell cycle regulation (Eldeiry et al., 1993). In addition, p53 has also been 
widely reported to be the major regulator of p21 for another role in G2/M cell cycle 
checkpoint (Reviewed in Taylor and Stark 2001). To investigate whether in ZS cells, the 
upregulation of p21 and its involvement in G2/M arrest were modulated by p53, the gene 
knock-down approach with p53 siRNA was applied. Firstly, p53 protein level was found 
to be induced to more than 2 folds higher in ZS cells than ZN cells (Figure 21). By 
transfecting graded amounts of p53 siRNA (600, 400, and 200 pmole per plate), the 
amount of p53 siRNA at 200 pmole per transfection was found to be able to abrogate the 
amount of elevated p53 protein level in ZS cells and normalize it to that of ZN control 
cells. The same batch of cells with normalized p53 protein level in ZS cells were used for 
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p21 protein level measurement. Interestingly, in ZS-si-p53 cells with normalized p53 
level, the originally elevated p21 protein level was found to be abolished and reduced to 
the level almost identical to that of ZN control cells (Figure 22). In addition, ZN cells 
transfected with the same amount of p53 siRNA showed a near 40% decrease in p21 
protein level than ZN control cells. Next, the ZS cells, with normalized level of p53 
protein, were used for cell growth determination. 
 
Normalization of p53 protein level in ZS cells with p53 siRNA alleviates the G2/M 
blockage and restores depressed cell growth 
p53 is a well known tumor suppressor gene. In response to various stresses, 
upregulation of p53 induces immediate downstream target, p21, which arrests cell cycles 
at different phases for DNA repair (El-Deiry et al., 1993; Harper et al., 1993; Xiong et al., 
1993). To establish that G2/M blockage is caused by elevated p53 expression, ZS-si-p53 
cells with normalized p53 protein level were subjected to cell cycle analysis by flow 
cytometry. The result indicated that (Figure 23), with normalized p53 protein in ZS cells, 
the normalization of p53 protein level in ZS cells alleviated the G2/M blockage from 
22.5% and normalized it back to 14 % which was similar to the % of ZN control cells in 
G2/M phase. As for ZN cells transfected with same amount of p53 siRNA, the percentage 
of cells in G2/M was slightly reduced. Furthermore, the original growth repression was 
abolished and cell growth was restored back to almost the same level of ZN control cells 
(Figure 24). In addition, in ZN cells transfected with the same amount of p53 siRNA, a 
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Figure 13 Zinc-supplemented medium depresses NHBE cells growth 
 
Fig. 13: NHBE cells were cultured for one passage in basal medium depleted of zinc 
to induce zinc-deficient (ZD) cells or in the basal medium supplemented with 4.0, 
16, or 32 μM zinc to represent the amount of zinc in most normal media (ZN), the 
normal human plasma zinc level (zinc-adequate, ZA), or the high end of plasma zinc 
attainable by oral supplementation (ZS), respectively. Cellular zinc was measured by 
atomic absorption spectrophotometry. Cellular zinc levels were expressed as a 
percentage of ZN controls. Values are means ± SEM from 3 experiments. Different 









Fig. 13: Cell numbers were counted by using hemacytometer. Cell number was 
counted count as per plate and expressed as a percentage of ZN controls. Values are 
means ± SEM from 3 experiments. Different letters indicate significant different 

















Figure 14 High intracellular zinc status induces G2/M blockage 
 
Cell cycle analysis of NHBE cells was assayed by flow cytometry using a 
FACScalibur cytometer. Cells were cultured in ZD, ZN, ZA, and ZS media for one 
passage. Washed cells were fixed in ethanol and stained with propidium iodide for 
DNA content. Flow cytometric data files were collected and analyzed using the 
CELLQuest program. Cell cycle distribution percentages of stained nuclei were 
calculated using Modfit LT software. The calibration standard LinearFlow green 
and the DNA QC particle kit were used for verification of instrument performance. 
Histograms are representative of three independent experiments. The proportions 
of cells in G0/G1, S phase and the G2/M ratios are indicated for each treatment 






















 Figure 15 High intracellular zinc status induces p21 mRNA level 
 Total RNA was isolated from cells by using RNeasy Kit (Qiagen, Valencia, CA). 
The abundance of p21 mRNA was measured by using a nonradioactive RPA kit 
(BD Biosciences, San Diego, CA) according to the manufacturer’s instructions. 
The RPA probe set, which included p21 and GAPDH probe, was from the same 
manufacturer. The optical densities of the protected p21 bands were quantified 
by the Alpha Innotech imaging system (San Leandro, CA) and then normalized 
to that of GAPDH. Values shown in bar graphs represent means ± SEM from 3 
separate experiments. Data were analyzed by one-way ANOVA. Different letters 
indicate significantly different means (P<0.05); while means with the same letter 



























Figure 16High intracellular zinc status induces p21 protein level  
Nuclear proteins (40 μg) prepared from NHBE cells were separated on SDS-
PAGE, Western blotted, and probed with antibody p21 (C-19). The nuclear 
protein p21 band was normalized to the corresponding housekeeping gene, 
Oct-1, and expressed as a percentage of ZN cells. Values shown in bar graphs 
represent means ± SEM from 3 separate experiments. Data were analyzed by 
one-way ANOVA. Different letters indicate significantly different means 





















Figure 17. High intracellular zinc status enhances p21 promoter activity 
 
NHBE cells were cultured in media with respective zinc concentration (ZD = 0
µM; ZN = 4 µM; ZA = 16 µM; and ZS = 32 µM zinc supplemented to the basal 
medium) for 4 days. Thereafter, cells were transiently transfected with 500 ng of 
luciferase reporter construct (PGL3-p21) containing the p21 promoter, together 
with 10 ng pRL-SV40 as internal control. PGL3 basal vector without carrying any 
promoter was used as the vector control. After transfection, the cells were cultured 
in corresponding media for 2 more days. Cells extracts were then assayed by Dual-
Luciferase reporter system and signals were measured by a Luminometer. Values 
represent means ± SE from 3 experiments. Data were analyzed by one-way 
ANOVA. Different letters indicate significantly different means (P < 0.05); while 


























Figure 18. Transfection of p21 siRNA, at 200 pmole/plate, abolishes the induced 
p21 protein level in zinc supplemented NHBE cells. 
 
 
NHBE cells were cultured in media with respective zinc concentration (ZN = 4 µM 
and ZS = 32 µM) for 4 days. Thereafter, cells were transiently transfected with 
graded amounts of p21 siRNA (600, 400 and 200 pmole/plate). After transfection,
the cells were cultured in corresponding media for 2 more days. Total proteins were 
then extracted and subjected to protein expression analysis by western-blot. Values 
represent means ± SE from 3 experiments. Data were analyzed by one-way 
ANOVA. Different letters indicate significantly different means (P < 0.05); while 




















 Figure 19. G2/M blockage in zinc supplemented NHBE cells is released after 
normalization of p21 protein level.  
 In cell cycle analyses, DNA content of NHBE cells was assayed by flow 
cytometry using a FACScalibur cytometer. Cells were cultured in respective zinc 
concentration (ZD and ZN) for 4 days. Thereafter, cells were transiently 
transfected with 200 pmole p21 siRNA per plate. After transfection, cells were 
cultured in corresponding media for 2 more days. Washed cells were fixed in 
ethanol and stained for DNA content. Flow cytometric data files were collected 
and analyzed using the CELLQuest program. A total of 10,000 cells events were 
collected for DNA analyses. Cell cycle distribution percentages of stained nuclei 
were calculated using Modfit LT software. The calibration standard LinearFlow 
green and DNA QC particle kit were used for verification of instrument 






















 Figure 20. Cell growth depression in zinc supplemented NHBE cells is 
abolished after abrogation of induced p21 protein level  
 NHBE cells were cultured in media with respective zinc concentration (ZN = 4
µM and ZS = 32 µM) for 4 days. Thereafter, cells were transiently transfected 
with either p21 siRNA at concentration of 200 pmole/plate or Luc siRNA as a 
negative control. After transfection, the cells were cultured in corresponding 
media for 2 more days. Total cell numbers were counted using hemacytometer
and was expressed as % of ZN control. Values represent means ± SE from 3 
experiments. Data were analyzed by one-way ANOVA. Different letters 
indicate significantly different means (P < 0.05); while means with the same 

























 Figure 21. Transfection of p53 siRNA, at 200 pmole/plate, abolishes the 
induced p53 protein level in zinc supplemented NHBE cells.  
 NHBE cells were cultured in media with respective zinc concentration (ZN = 4
µM and ZS = 32 µM) for 4 days. Thereafter, cells were transiently transfected 
with graded amounts of p53 siRNA (600, 400 and 200 pmole/plate). After 
transfection, the cells were cultured in corresponding media for 2 more days. 
Total proteins were then extracted and subjected to protein expression analysis 
by western-blot. Values represent means ± SE from 3 experiments. Data were 
analyzed by one-way ANOVA. Different letters indicate significantly different 























Figure 22. Zinc supplemented NHBE cells with normalized p53 protein 
level abrogate the elevated p21 level. 
 
 
NHBE cells were cultured in media with respective zinc concentration (ZN = 4
µM and ZS = 32 µM) for 4 days. Thereafter, cells were transiently transfected 
with p53 siRNA at concentration of 200 pmole/plate. After transfection, the 
cells were cultured in corresponding media for 2 more days. Total proteins 
were then extracted and subjected to p21 protein expression analysis by 
western-blot. Values represent means ± SE from 3 experiments. Data were 
analyzed by one-way ANOVA. Different letters indicate significantly different 

























Figure 23. G2/M blockage in zinc supplemented NHBE cells is released after 
normalization of p53 protein level. 
In cell cycle analyses, DNA content of NHBE cells was assayed by flow cytometry 
using a FACScalibur cytometer. Cells were cultured in respective zinc concentration 
(ZD and ZN) for 4 days. Thereafter, cells were transiently transfected with 200 pmole 
p53 siRNA per plate. After transfection, cells were cultured in corresponding media 
for 2 more days. Washed cells were fixed in ethanol and stained for DNA content. 
Flow cytometric data files were collected and analyzed using the CELLQuest 
program. A total of 10,000 cells events were collected for DNA analyses. Cell cycle 
distribution percentages of stained nuclei were calculated using Modfit LT software. 
The calibration standard LinearFlow green and DNA QC particle kit were used for 













Figure 24. Cell growth depression in zinc supplemented NHBE cells is 
abolished after abrogation of induced p53 protein level 
 
 
NHBE cells were cultured in media with respective zinc concentration (ZN = 4
µM and ZS = 32 µM) for 4 days. Thereafter, cells were transiently transfected 
with either p53 siRNA at concentration of 200 pmole/plate or Luc siRNA as a 
negative control. After transfection, the cells were cultured in corresponding 
media for 2 more days. Total cell numbers were counted using hemacytometer
and was expressed as % of ZN control. Values represent means ± SE from 3 
experiments. Data were analyzed by one-way ANOVA. Different letters indicate 
significantly different means (P < 0.05); while means with the same letter 















        In a previous study (Shih et al., 2006), we have reported that in ZS NHBE cells, the 
enhancement of cellular zinc status depressed G2 to M phase progression, which resulted 
in cell growth reduction. Moreover, Gadd45 induction in ZS NHBE cells was found to be 
partially responsible for the depressed G2/M progression. In view of available evidence 
indicating that p21, which is a major cell regulator at G1 and is also involved in G2/M 
regulation (Dulic et al., 1998), we have designed the present study to examine if p21 and 
p53 expression are affected and whether they are also involved in the G2/M arrest in zinc 
supplemented NHBE cells.  
 
In the present report, we have presented multiple lines of evidence for the first time 
to substantiate that the transcriptional process and expression of p21 are upregulated in 
zinc-supplemented NHBE cells in primary culture. The observed induction of almost 2-
fold higher nuclear p21 protein and p21 mRNA in ZA and ZS cells than control ZN cells 
(Fig. 15 & 16) indicates that the transcriptional process is enhanced in zinc-supplemented 
cells. The p21 promoter activity was measured to address the question whether induced 
expression of mRNA and protein were caused by an upregulation of promoter activity. A 
similar pattern of induction of p21 promoter activity, as in p21 mRNA and protein levels, 
was observed in ZA and especially ZS cells as compared to ZN cells (Fig. 17). These 
findings indicate that an enhanced promoter activity, instead of another mechanism such 
as mRNA stability, may be mainly responsible for the upregulation of p21 gene and 
protein expression.  
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Available evidences indicate that p21 is involved in G2/M transition. For example, 
in human fibroblasts, p21 mRNA abundance shows bimodal periodicity with peaks in G1 
and G2/M (Li et al., 1994) and that nuclear p21 protein reaccumulates at the onset of 
mitosis (Dulic et al., 1998). On top of this, inducible p21 expression was demonstrated to 
be responsible for cell cycle arrest at both G1 and G2 (Carol et al., 1998). By 
synchronizing the cell population at S phase, p21 was found to induce G2 arrest in human 
fibroblasts cells (Smits et al., 2000). With circumstantial evidences suggesting that p21 
may also be involved in G2/M checkpoint, we have designed the present study to 
investigate if the enhanced p21 level in ZS cells was associated with the G2/M arrest. A 
gene knock-down approach was employed to examine if G2/M blockage would be 
alleviated after abrogation of the enhanced p21 expression in ZS cells. By transfecting 
graded amounts of p21 siRNA, the transfection of siRNA at 200 pmole/plate was found 
to abolish the elevated level of p21 protein in ZS cells to that of ZN cells (Fig. 18). The 
ZS-si-p21 cells with normalized level of p21 protein were subjected to cell cycle analysis. 
The result indicated that, after the normalization of p21 protein level in ZS cells, the 
original G2/M blockage was alleviated to the same level in ZN control cells (Fig.19). 
While for ZN cells transfected with same amount p21 siRNA, G2/M cell cycle transition 
was slightly reduced as compared with ZN control cells. Moreover, alleviated G2/M 
blockage in ZS cells with normalized p21 protein level was also accompanied by a 
normalized cell growth. The original growth repression in ZS cells was abolished and cell 
growth was restored to a similar level as in ZN controls cells (Fig. 20). Thus, the 
elevation of p21 expression in zinc supplemented NHBE cells is largely if not entirely 
responsible for the observed G2/M blockage as well as growth repression induced by 
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high zinc status in NHBE cells. In fact, three mechanisms have been proposed for how 
upregulation of p21 participates in inhibiting Cdc2 activity to cause G2 arrest. First, p21 
directly binds to cdc2/cyclin B1 complexes and inhibits Cdc2 activity (Boulaire et al., 
2000). p21 was found in Cyclin B1 immunoprecipitates in cells overexpressing p21 
(Medema et al., 1998; Taylor et al., 1999b). However, in some studies, it was not found 
in Cyclin B1 immunoprecipitates (Bates et al., 1998; Dulic et al., 1998). It was suggested 
that binding to Cdc2/Cyclin B1 may be only observed when there are very high levels of 
p21 (Taylor and Stark 2001). A second mechanism for inhibiting Cdc2 has been 
suggested by a report showing that p21 may inhibit Cdk2, which is an activator of Cdc2, 
and resulted in the loss of Cdc2 activity (Guadagno and Newport, 1996). A third 
mechanism of Cdc2 inhibition by p21 was suggested by the report of Smits et al. (2000) 
which showed that overexpression of p21 reduced the phosphorylation of Cdc2 on 
threonine 161 and the Cdc2 activity. By adding recombinant CAK protein, which 
phosphorylated Cdc2 on threonine 161, the immunoprecipitated Cdc2 activity was 
restored (Smits et al., 2000).  
 
Next, we investigated if the elevation of p21 expression in ZS cells was dependent 
on p53. Although p53-independent regulation of p21 expression has been widely reported, 
p53 is still well recognized as a major immediate upstream regulator of p21 expression 
(Eldeiry et al., 1993). In particular, in the modulation of G2/M progression, p53 has been 
proposed to employ p21 in the regulation of Cdc2/Cyclin B complex activity, which is a 
cell cycle regulator of G2 to M transition (Reviewed in Taylor and Stark 2001). In ZS 
cells, p53 was found to be induced to almost 2-fold higher than ZN control cells (Fig 21). 
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The magnitude of elevation of p53 is similar to that of p21 protein. Therefore, a similar 
gene knock-down approach used to examine if p21 protein induction would be dependent 
on p53 expression. By testing graded amounts of p53 siRNA, the transfection of 200 
pmole of siRNA per plate was found to abolish the elevated level of p53 protein in ZS 
cells and normalized it to that of ZN cells (Fig. 22). The ZS-p53-siRNA cells, with 
normalized level of p53 protein, were subjected to p21 protein measurement as well as 
cell growth determination. Our results indicated that in ZS-siRNA cells, after the 
normalization of p53 protein level, the original 2-folds elevated p21 protein was 
abolished and the protein level was normalized to a level as in ZN control cells (Fig. 22). 
The ZN cells transfected with same amount of p53 siRNA showed 50% less p21 protein 
than that of ZN control cells, indicating the efficacy of p53 knock-down by using p53 
siRNA. Next, the ZS-si-p53 cells with normalized level of p53 protein were subjected to 
cell cycle analysis to examine if G2/M arrest would be alleviated. The result indicated 
that, after the normalization of p53 protein level as in ZS cells, the original G2/M 
blockage was alleviated to the same level in ZN control cells (Fig. 23). However, for ZN 
cells transfected with same amount p53 siRNA, the G2/M cell cycle transition was only 
slightly reduced as compared with ZN control cells. Furthermore, with the normalization 
of p53 protein in ZS-si-p53 cells, original growth repression was abolished and cell 
growth was restored back to 20% higher than ZN control cells (Fig. 24). This result is 
consistent with previous contention that p53 functions as a negative growth regulator. In 
addition, ZN cells transfected with the same amount of p53 siRNA showed an almost 
40% higher cell growth than ZN control cells. Thus, high intracellular zinc content 
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appeared to induce p53 which in turn lead to the elevation of p21 gene expression, 
blockage of G2/M progression and suppression of cell proliferation. 
 
Several studies have indicated that high cellular zinc may exert adverse effect on 
human cell growth (Bataineh et al., 2002; Feng et al., 2000; Uzzo et al., 2002). Moreover, 
studies also reported that treatment with high level of zinc inhibited cancer cells 
proliferation by mediating G2/M arrest (Jaiswal et al 2004; Liang et al., 1999). In one 
report, human primary liver cells cultured in 100 μM zinc were found to exhibit DNA 
fragmentation (Paramanantham et al., 1996). However, the present report is the first to 
show that 32 μM of zinc concentration, which represents the high end of plasma zinc 
attainable by oral supplementation, can cause G2/M arrest and cell growth repression in 
primary cell line. In our NHBE study, the cytotoxic stress induced by zinc 
supplementation may be one of the stress factors that elevates p53 expression, which then 
suppress G2/M progression through the upregulation of cyclin dependent kinase inhibitor, 
p21. In fact, preliminary results in our laboratory indicated that the amount of 
endogenous reactive oxygen species (ROS) generated in ZS NHBE cells was higher than 
that in ZN cells (Shih et al., 2006). Reactive oxygen species have been implicated in 
DNA damage by genotoxic agents such as UV and ionizing radiation or doxorubicin. 
Subsequent accumulation of ROS-damaged DNA is a critical event during carcinogenesis 
and aging (Ames et al., 1993). DNA damage triggers a variety of signaling pathways that 
lead either to apoptosis or to DNA damage repair that is coupled with cell cycle 
regulation. One junction of such pathways is controlled by the tumor suppressor protein 
p53. The principal function of p53 is to promote survival or apoptosis of cells exposed to 
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agents that cause DNA damage, such as hypoxia, UVR, ROS or mutagens (Graeber et al., 
1996; Renzing et al., 1996; Clarke et al., 1997; Griffiths et al., 1997). The p53 protein is 
involved in complex cellular responses to DNA damage. These responses involve DNA 
editing and repair followed either by normal cell division (Polyak et al., 1997) or by 
apoptosis (Hale et al., 1996). Cells damaged by UVR and oxidative stress often remain in 
the G1/G2-phase of the cell cycle for long periods (Evan and Littlewood, 1998). 
Therefore, the oxidative stress induced in ZS cells may trigger the upregulation of p53 
signal transduction pathway that causes the G2/M arrest in our cell system. 
 
In summary, the present data suggest that the upregulation in p53 expression in 
zinc supplemented NHBE cells resulted in an elevation of p21 expression, which 
contributed to the G2/M blockage. Moreover, the oxidative stress induced in zinc 
supplemented NHBE cells may be the possible trigger of p53 signal transduction pathway 












Chapter V: Summary 
 
 
In HepG2 cells, nuclear and cytoplasmic p21 protein levels in the ZD and ZD0.4 
cells were significantly repressed when compared to ZN control cells. The p21 mRNA 
levels in ZD and ZD0.4 cells were also repressed compared to ZN cells. In contrast, no 
significant differences were detected in nuclear and cytoplasmic p21 protein levels as 
well as p21 mRNA abundance among the ZN, ZA, ZS, and ZD+32 μM cells. Most 
importantly, the ZD+32 μM rescue approach demonstrated the specificity of zinc 
treatment and the rapid normalization of both p21 protein and mRNA levels by zinc 
replenishment. The p21 promoter activity of ZD and ZD0.4 cells was significantly 
reduced to 64% and 66% of ZN cells, respectively. In contrast, no differences were 
observed among the ZA, ZS, ZD+32 μM, and ZN cells. However, supplementation of ZD 
cells with ZS medium (ZD+32 μM), for the last 2 days of culture, was able to normalize 
the p21 promoter activity to that of the ZN cells. This rescue approach shows the 
specificity of zinc treatment and the speed of normalization of p21 promoter activity by 
zinc replenishment. 
 
By transfecting graded amounts of PCMV-p21 plasmid (1, 3, 5, 7, 10 microgram 
per plate), which constitutively expressed p21, the amount of PCMV-p21 at 5 µg per 
transfection was capable of restoring the p21 expression level in the PCMV-p21 
transfected ZD cells (ZD+5) back to the level of ZN control cells (ZN+0). In addition, 
ZN cells transfected with 5 µg of PCMV-p21 (ZN+5) demonstrated a 48% increase in 
p21 protein level than ZN control cells (ZN+0). Most interestingly, after the transfection 
of 5µg PCMV-p21, the cyclin D1-cdk4 complex activity was normalized in ZD cells but 
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was not altered in ZN cells as compared to ZN cells transfected with control plasmid. As 
a control to assess the quality of the lysate, equivalent amount of the lysate from both ZD 
and ZN cells transfected with PCMV-p21 or PCMV-control plasmids were 
electrophoresed by SDS-PAGE and immunoblotted with mAb anti-G3PDH and were 
found to be optimal among all treatments. Thus, the results indicated that the small 
reduction in cyclin D-cdk4 complex activity appeared to be the result of the decreased 
p21 protein level in ZD cells. 
 
Cell growth and cell cycle progression analyses were also determined in the same 
batch of cells used for the measurement of cyclin D1-cdk4 complex activity after the 
rescue of p21 level in ZD cells. The result demonstrated that cell growth remained 
repressed in ZD PCMV-p21 cells, with normalized p21 expression, as compared to ZD-
PCMV-control cells. Most importantly, in the ZN-PCMV-p21 cells transfected with the 
same amount of PCMV-p21 plasmid, the marked increase in p21 expression was 
accompanied by a 30% reduction in cell growth, which illustrated the growth inhibitory 
effect of p21 expression at high level. Furthermore, cell cycle progression is impaired at 
the G1/S phase in ZD cells. However, the impaired G1/S cell cycle progression remained 
unchanged in the ZD-PCMV-p21 cells, with normalized p21 level and cyclin D1-cdk4 
complex activity. Moreover, the G1/S progression was mildly impaired in the ZN-
PCMV-p21 cells, with markedly elevated p21 protein level, which indicated that the 
overexpressed p21 was functionally effective in inhibiting cell cycle progression and 
growth. Thus, these findings suggested that, in zinc-deficient HepG2 cells, the decreased 
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p21 protein level was not responsible for the associated inhibition of cell growth and cell 
cycle progression. 
 
 In NHBE cells, p21 mRNA levels in the ZA and ZS cells was drastically 
upregulated to almost 200% of ZN control cells. Consistent with the pattern of p21 
mRNA expression, nuclear p21 protein levels in ZA and ZS cells was similarly 
upregulated. In contrast, no significant differences were detected in nuclear p21 protein 
and p21 mRNA levels between the ZD and ZN cells. Transient transfection of a p21-
promoter-luciferase reporter gene into NHBE cells established that the p21 promoter 
activity of ZS cells was also significantly induced to 150% and 200% of ZN cells, 
respectively. In contrast, no difference was detected between ZD and ZN cells.  
  
 The transfection of graded amounts of p21 siRNA (600, 400, and 200 pmole per 
plate) was used to establish that 200 pmole per transfection was able to abrogate the 
elevated  p21 protein level in ZS cells and normalize it to that of ZN control cells. In 
addition, an almost 20% decrease in p21 protein level was observed in ZN cells 
transfected with 200 pmole of p21 siRNA than ZN control cells. After knocking down 
the induced protein level of p21 in ZS cells to a similar level as in ZN cells with p21 
siRNA, the cells were subjected to cell cycle analysis to examine the association of p21 
induction with G2/M arrest in ZS cells. The present findings indicated that the 
normalization of p21 protein level in ZS-si-p21 200 pmole cells alleviated the G2/M 
blockage from 20% and normalizes it back to 12%. As for ZN cells transfected with same 
amount of p21 siRNA, there were little or no reduction in the percentage of cells in G2/M. 
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In ZS-si-p21 cells, the normalization of p21 protein level by using p21 siRNA restored 
the originally depressed cell growth of ZS cells back to the same level of ZN control cells. 
To investigate whether in ZS cells, the upregulation of p21 and its involvement in G2/M 
arrest were modulated by p53, the gene knock-down approach with p53 siRNA was 
applied. Firstly, p53 protein level was induced to more than 2-fold higher in ZS cells than 
ZN cells. The transfection of graded amounts of p53 siRNA (600, 400, and 200 pmole 
per plate) was used to establish that 200 pmole of p53 siRNA at per transfection was able 
to abrogate the elevated p53 protein level in ZS cells and normalize it to that of ZN 
control cells. Interestingly, in ZS-si-p53 cells with normalized p53 level, the originally 
elevated p21 protein level was abolished and normalized to the level almost identical to 
that of ZN control cells. In addition, ZN cells transfected with the same amount of p53 
siRNA demonstrated an almost 40% decrease in p21 protein level than ZN control cells. 
To establish that G2/M blockage was caused by the elevated p53 expression, ZS-si-p53 
cells with normalized p53 protein level were subjected to cell cycle analysis by flow 
cytometry. The normalization of p53 protein level in ZS-si-p53 cells was found to 
alleviate the G2/M blockage from 22.5% and normalized it back to 14 % as in ZN control 
cells. As for ZN cells transfected with 200 pmole of p53 siRNA, there was little or no 
reduction in the percentage of cells in G2/M. In addition, the original growth repression 
was abolished and cell growth was restored back to almost the same level of ZN control 
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